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Cell are the basic structural, functional, and biological units of all known living 
organisms. Understanding the physiological behaviors of living cells and tissues is a 
prerequisite to further advance bioscience and biotechnologies, such as synthetic biology, 
stem cell manufacturing, and regenerative medicine. Moreover, both wide-type and 
genetically modified cells have been widely used as powerful sensing and diagnostic tools 
in cell-based assays; these assays are the key enablers in numerous high-impact 
applications, including characterizing the potency and toxicity of new drugs in pre-clinical 
pharmaceutical development, determining the patient-specific treatments in personalized 
medicine, fast pathogen screening for epidemic disease detections, and detecting 
biohazards and pollutants in environmental monitoring. However, cells are highly complex 
systems with numerous molecules operating in hundreds of pathways to maintain their 
proper functions, phenotypes, and physiological behaviors. With this daunting scale of 
complexity, cells often undergo concurrent multi-physics responses when subjected to 
external biochemical stimuli or physiological condition shifts. On the other hand, existing 
integrated electronic sensors are mostly of single-modality to capture one category of 
cellular physiological responses, e.g., neural recording and stimulation systems for 
measuring neuron activities, electrical impedance sensors for cell-growth assay and 
detecting myocardial ischemia, pH sensors for cellular metabolism assay, magnetic cell-
based sensor for measuring cardiac beating rate, and optical sensors for DNA sequencing. 
Such single-modality sensors fundamentally cannot capture the complex multi-physics 
cellular responses and largely limit our understanding on the cellular behaviors and 
dynamics. This is particularly true for drug screening application. When cells are exposed 
to drug or biochemical stimulus, cells exhibit complex behaviors that demand multi-
 xvi
physics and multi-parametric modeling. The key objective is to real-time capture multi-
physical cellular physiological responses from the same cellular sample with a high 
spatiotemporal resolution. In addition, it is highly desired to support cellular stimulations 
or actuations, which enable various in-depth cellular studies. For example, electrical 
stimulation promotes the cardiac differentiation of human cardiac progenitor cells and the 
maturation of cardiomyocytes derived from human embryonic stem cells, and it also can 
be used to study cellular behaviors under various neurological and cardiovascular diseases. 
To address these challenges, my Ph.D research focuses on investigating CMOS 
multimodality cellular sensing/actuation array platforms to achieve (1) simultaneous 
detections of multiple orthogonal cellular physiological responses in each array pixel, (2) 
arbitrarily reprogrammable and multi-site concurrent electrical cellular stimulations, (3) 
single-cell resolution array pixel, and (4) on-chip signal processing units for rapid and self-
contained cellular diagnostics. In addition, since the platform is directly interfacing with 
living cells, I have investigated on (5) the biocompatibility of the CMOS sensor, including 
electro-less gold plating on microscale aluminum electrodes, protein coatings, and high 
solution resistance and reliable biocompatible packaging techniques, which is particularly 
important to successfully culture living cells on the sensor surface and to study long-term 
drug effects. Furthermore, I have investigated on (6) the culturing various living cells such 
as neurons, cardiomyocytes, fibroblast, and cancer cells on the fully packaged CMOS 
sensor array for in vitro cell-based experiments.   
My proposed platforms will enable real-time holistic cellular characterization and 
impact many areas including drug screening, stem cell manufacturing, regenerative 
medicine, implantable bioelectronics, and neural/cognitive sciences. Moreover, my 
proposed platforms will open the door to future hybrid biotic/abiotic (cells/semiconductor) 







All living things are made up of cells and cells are the smallest and the most basic 
structural and functional building blocks for life [1]-[3]. The characterization of 
physiochemical behavior of cells and the understanding the cellular and molecular 
mechanisms are the first step for the scientific progress in biotechnologies and biosciences 
such as synthetic biology [4] stem cell manufacturing [5] and regenerative medicine [6].  
Cell based assay has been widely used for cell characterization and drug screening due to 
its unique advantages (Fig. 1.1). Since it directly uses living cells, it provides 
physiologically relevant information and offers an accurate representation of a real-life 
model. It also achieves a high sensitivity and responses can be very fast. Recently, cell-
based assay has gained tremendous interest for new emerging applications such as a drug 
discovery, epidemic disease detections, and an environmental monitoring for detecting bio-
hazards and pollutants. In particular, cell-based assay has a great potential in a personalized 
medicine as the patient derived cells can be directly used to test a potency, efficacy, and 
toxicity of a newly developed patient-specific medicine.  
However, cells are highly complex system with multi-physics and multi-parametric 
activities. For example, cells perform chemical activities such as anabolism (the synthesis 
of complex organic molecules from simple organic molecules with the storage of energy) 
and catabolism (the breakdown of complex organic molecules to simple organic molecules 
with the release of energy) and mechanical activities such as movement towards the 
external stimuli such as chemicals (chemotaxis), photons (phototaxis), and hormones. 
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Furthermore, cells can harvest and utilize energy. For example, most of cells perform 
cellular respiration and plant cells undergo photosynthesis.  
 
 
Fig. 1.1. Cell-based sensor and actuator. 
 
A variety of single-modality cell-based sensors and actuators have been proposed 
and successfully demonstrated to capture one type of physiological changes. For a potential 
recording, patch pipettes which penetrates into the cell membrane and measure the 
intracellular potentials have been widely used. However, it requires bulky and dedicated 
mechanical setup and therefore, not suitable for the large-scale high-throughput 
applications. Moreover, since it is invasive type of contact, it cannot support long-term 
recording. To address these challenges, recently, an extracellular potential recording using 
microelectrode array has gained tremendous interest. In particular, microelectrode array 
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together with read-out circuits fully integrated in CMOS platform has been an active 
research area [7]-[9]. A CMOS low-noise bio-amplifier that employs PMOS pseudo 
resistors, operational amplifier, and capacitors achieves low cut-off frequency of 0.025Hz 
and low input-referred noise of 2.2µVrms integrated from 0.025Hz to 7.2kHz and cell-
based measurement results demonstrate extracellular action potential recording of rat 
olfactory cortex in the paper [7]. A large-scale high-throughput extracellular potential 
recording of on-chip cultured snail neuron is also demonstrated with 128×128 
microelectrode array with the electrode pitch size of 7.8µm [8]. Furthermore, in order to 
study plasticity and learning process, in-situ electrical stimulation is added in the 
microelectrode sensor array and a 1024-channel extracellular potential recordings after an 
electrical stimulation are demonstrated in the paper [9].  
Electrical impedance sensing has been widely used to capture electrochemical 
activities of bio-samples [10]-[12]. A 10×10 sensor array integrated in a standard CMOS 
process [10] demonstrates the detection of a wide variety of DNAs and proteins in real time 
without a molecular label using an electrochemical impedance spectroscopy. In the paper 
[11], a 16×8 array integrated in CMOS demonstrates a successful detection of DNAs by an 
electrochemical redox cycling process. It is also recently reported in the paper [12] that 
two pair of microelectrodes are integrated in the hanging drop network to monitor the size 
of micro-tissue spheroids, e.g., the cancer cell growth assay, and to measure the beating 
rate of cardiac micro-tissues.     
Optical measurements are one of the most accurate and fundamental measurement 
methods and therefore, have been widely used for bio-sample characterizations. However, 
optical measurements often require bulky and very expensive instruments such as a lens, 
laser source, and optical filter. In order to address these challenges, many efforts have been 
made to develop a cost-efficient and miniaturized optical sensor for point-of-care and 
point-of-use applications [13]-[15]. A CMOS fluorescent-based biosensor microarray is 
proposed in the paper [13] that CMOS sensor array chip, thin-film optical long-pass filter, 
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and fiber-optical faceplate are integrated and packaged together as a single chip module 
and successfully measures DNA hybridization kinetics. Note that the thin-film optical 
long-pass filter (20 layers with the total thickness of 2.1µm) is directly deposited on top of 
the CMOS sensor chip together with a fiber-optical faceplate (wave-guide) to achieve the 
excitation light rejection of 98dB. In order to further reject the excitation light or potentially 
obviate the use of an optical filter, the time-resolved or time-gated fluorescence detection 
method implemented in CMOS process is also reported in the paper [14]. On the other 
hand, a bioluminescent detection with a fiber-optic faceplate and immobilized luminescent 
reporters is reported in the paper [15]. A 8×16 array is implemented in CMOS and 
successfully demonstrates DNA sequencing by measuring emitted visible light intensity 
using a linked enzymatic reaction in the paper [15]. 
 
 
Fig. 1.2. Summary of the cell-based sensors and actuators. 
 
However, the existing single-modality sensors can only capture one-type of cellular 
physiological changes and require additional efforts to capture multi-physical cellular 
responses. For example, bio-samples can be sequentially transferred through multiple 
Extracellular potential 
recording
Seizure detection, neuroprosthetics, cardiac arrhythmia, 
action potential propagation, etc. 
Sensing modality Physiological measurements Sensing circuits
Low-noise voltage amplifier 
(Sub-Hz to KHz)
Detection of a wide variety of DNAs and proteins, cardiac 
beating rate, myocyte ischemia, cell growth  
Complex impedance 
measurement
Fluorescent detection DNA hybridization kinetics, fluorescent imaging, etc.
Voltage excitation and current 
sensing (KHz to MHz)  
Photo-diode and thin film 
optical filter  
Optical detection Bioluminescent detection, DNA sequencing, cell growth, cell viability, cardiomyocyte contraction/relaxation Photo-diode
Electrical stimulator Neurological and cardiovascular diseases, sensory modality lost, cardiomyocytes maturation and differentiation 
5 bit active charge balancing 
current sources
Cell metabolism assay,   PH sensing ISFET
Cell movement tracking, cardiac muscle contraction/
relaxation   Magnetic sensing Inductor
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single-modality sensors. However, it suffers from potential abrogation of cell functions and 
results in low throughput. Parallel monitoring of multiple cell samples each with different 
single-modality sensor can be another feasible method to capture multi physical cellular 
behaviors. However, significant sample-sample variations often exist and result in a 
compromised biological correlation amount the different modality measurements.         
To address these unmet challenges, we propose a multimodality sensor array fully 
integrated in a standard CMOS process for holistic cell characterization and high 
throughput drug screening [16]-[20]. The proposed multimodality sensor array contains tri-
modality pixels including an optical detection (photo diode), a complex impedance sensing 
(voltage excitation and current sensing), and an extracellular potential recording (low-noise 
bio-potential amplifier) and a temperature sensor. The extracellular potential recording 
modality can detect the action potential (300Hz to 20kHz) and/or the local filed potential 
(1Hz to 300Hz) of the electro-genic cells such as neurons and cardiomyocytes. Complex 
impedance sensing modality can measure cell-to-sensor surface attachment, cell growth, 
and the beating rate of cardiomyocytes. Optical detection can measure cell morphology, 
shape, and opacity changes as well as a cardiac muscle fiber contraction and relaxation. 
Also, it can be used for bioluminescent assay. To consider the effect of cellular 
physiological changes due to the ambient temperature variations, cellular environmental 
thermal monitoring is also required. In addition, it is highly desired to support cellular 
stimulations or actuations, which enable various in-depth cellular studies. For example, 
electrical stimulation promotes the cardiac differentiation of human cardiac progenitor 
cells [76] and the maturation of cardiomyocytes derived from human embryonic stem cells 
[77] and it also can be used to study cellular behaviors under various neurological and 




Fig. 1.3. Label-free drug discovery strategy. 
 
The high throughput multimodality sensor and stimulator arrays are particularly 
useful for drug discovery and drug development. Figure 1.3 shows drug discovery strategy 
[31]. It consists of following steps; diseases selection, phenotype screening, targets/hits 
identification, validation, and clinical trial. The details of the drug discovery process are 
explained as follows. After target diseases are selected, many libraries of compounds are 
screened in large panels of disease relevant cell lines based on the phenotype screening. 
Next, targets for specific phenotypes are identified, and hits are selected and identified 
based on the specific phenotype response. Finally, drug candidates are generated after 
validation. For phenotype screening, many combinations of diseases relevant cell lines and 
chemical compounds are investigated and thus this step is very time consuming and labor 
intensive. Furthermore, for successfully drug screening, multi-parametric and real-time 
kinetic measurements are of paramount importance, since cell signals could be encoded by 
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spatiotemporal dynamics and come in multiple pathways. The diseases relevant cellular 
phenotypes for drug screening application include morphological, structural, 
electrophysiological abnormalities. For example, cell proliferation, cell death, cell 
migration, cell division, inflammation, cell-to-cell communication, and cell signaling. 
Therefore, our proposed CMOS multimodality joint sensor and stimulator array has a great 
potential in drug screening application, supporting high throughput multi-parametric and 
real-time kinetic phenotype screening. 
1.2. Dissertation Outline 
This dissertation is organized as follows. In the chapter 2, we will present a proof-
of-concept design of a 144-pixel multimodality CMOS sensor array. Each multimodality 
pixel supports extracellular recording, optical sensing, and complex impedance 
measurement with the multimodality pixel size of 80µm×100µm. The human 
cardiomyocytes, mouse neurons, and human ovarian cancer cells are successfully cultured 
on the sensor array. The cell-based measurements results including extracellular recording, 
optical opacity imaging, bioluminescent assay, and complex impedance mapping are 
presented in chapter 2. Next, the biphasic current stimulator is added to the multimodality 
CMOS sensor array with improved pixel resolution and field of view. And a 1024-pixel 
CMOS multimodality joint sensor and stimulator array is presented in the chapter 3. Each 
multimodality pixel supports extracellular recording, optical sensing, biphasic current 
stimulation, and complex impedance measurement with the multimodality pixel size of 
58µm×58µm. The extensive cell-based measurements based on the on-chip cultured rat 
cardiomyocytes demonstrate the utility and the benefit of a proposed multimodality joint 
sensor and stimulator array in the chapter 3. In addition, details of the biocompatible 
packaging techniques are also presented in the chapter 3. The multimodality pixel 
resolution is further reduced to a single-cell resolution with wide field of view and a CMOS 
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22k-Pixel Single-Cell Resolution Multi-Modality Real-Time Cellular Sensing Array is 



















A 144-PIXEL MULTIMODALITY CMOS SENSOR ARRAY FOR 
CELL-BASED ASSAY AND DRUG SCREENING 
In this chapter, we present a fully integrated multi-modality CMOS cellular sensor 
array with four different sensing modalities to characterize different cell physiological 
responses, including extracellular voltage recording, cellular impedance mapping, optical 
detection with shadow imaging and bioluminescence sensing, and thermal monitoring. The 
sensor array consists of nine parallel pixel groups and nine corresponding signal 
conditioning blocks. Each pixel group comprises one temperature sensor and 16 tri-
modality sensor pixels, while each tri-modality sensor pixel can be independently 
configured for extracellular voltage recording, cellular impedance measurement (voltage 
excitation/current sensing), and optical detection. This sensor array supports multi-
modality cellular sensing at the pixel level, which enables holistic cell characterization and 
joint-modality physiological monitoring on the same cellular sample with a pixel resolution 
of 80µm×100µm. Comprehensive biological experiments with different living cell samples 
demonstrate the functionality and benefit of the proposed multi-modality sensing in cell-
based assay and drug screening. 
2.1. Introduction 
Cells, often called the “smallest building blocks of life”, are the basic structural, 
functional, and biological units of all known living organisms [1]-[3]. Fully understanding 
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the physiological behaviors of living cells and tissues is a prerequisite to further advance 
the frontiers in bioscience and biotechnologies, such as synthetic biology [4], stem cell 
manufacturing [5], and regenerative medicine [6]. Moreover, the physiological behaviors 
and responses of wide-type and genetically modified cells and tissues have been widely 
exploited as powerful tools in cell-based assays [32]. These assays are the key enablers in 
a plethora of high-impact applications, including characterizing the potency and toxicity of 
new drugs in pre-clinical pharmaceutical development [33] [34], determining the patient-
specific treatments in personalized medicine [35], fast pathogen screening for epidemic 
disease detections [36] [37], and detecting biohazards and pollutants in environmental 
monitoring [38] [39].  
 
Fig. 2.1. (a) The proposed multi-modality CMOS sensor array to capture the multi-
physics physiological behaviors of cells when exposed to drug or pathogen stimulus. 
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However, cells are highly complex systems with numerous molecules operating in 
hundreds of pathways to maintain their proper functions, phenotypes, and physiological 
behaviors [1]-[3]. With this scale of complexity, cells often undergo concurrent multi-
physics responses when subjected to external biochemical stimuli or physiological 
condition shifts (Fig. 2.1a).  
 
Fig. 2.1. (b) Sequentially transferring the cell samples through multiple single-modality 
sensors, resulting in a low throughput, potential abrogation of cellular functions, and 
incompatibility with concurrent joint-modality monitoring. (c) Parallel monitoring 
multiple cell samples with different single-modality sensors, suffering from sample-to-




On the other hand, existing microelectronic sensors are mostly of single-modality, 
which can only respond to one type of physiological signals, e.g., electrochemical [10] [11] 
[40] [41], or optical [13] [14] from the cells. Such single-modality sensors fundamentally 
cannot capture the complex multi-physics physiological responses of cells, thus limiting 
the understanding of the cellular behaviors and dynamics. Although one may sequentially 
transfer the cell samples through multiple microelectronic sensors each with a different 
sensing modality (Fig. 2.1b), this approach will result in a low throughput and potential 
abrogation of cellular functions. Moreover, it cannot support concurrent monitoring of 
multiple cellular responses under drug administration and is not compatible with terminal 
biochemical assays. Another approach is to perform parallel screening of multiple samples 
each with a different single-modality sensor (Fig. 2.1c). However, since the multi-physical 
responses are recorded based on different cellular samples, potential sample-to-sample 
variations will substantially compromise the biological correlation among the 
measurements of different modalities. 
To address these unmet challenges, we propose a fully integrated multi-modality 
cellular sensor array in CMOS. The sensor array includes nine parallel pixel groups, and 
each pixel group compromises one temperature sensor and 16 tri-modality sensor. 
Therefore, the entire sensor array can detect four distinct cell physiological responses, 
including extracellular voltage recording, cellular impedance mapping, optical detection 
with shadow imaging and bioluminescence sensing, and thermal monitoring [16] so that 
the multi-physics responses of the cells-under-test can be real-time characterized. 
Furthermore, this sensor array is compatible with standard low-cost CMOS processes. The 
proposed multi-modality sensor array offers a new cellular sensing platform, which allows 
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holistic understanding of cellular physiology, enables large-scaled high-throughput high-
content drug screening, and potentially revolutionizes cell-based assays in the future.  
This chapter is organized as follows. The proposed multi-modality sensor array 
system in CMOS is introduced in chapter 2.2. The sensor pixel design and programmable 
signal conditioning blocks are presented in chapter 2.3 and 2.4, respectively. The electrical 
measurements of the sensor array chip are shown in chapter 2.5. Extensive biological 
measurements using on-CMOS cultured cells are presented in chapter 2.6, demonstrating 
the use of the multi-modality CMOS sensor array in cell-based assays and drug detection. 
2.2. Multimodality Sensor Array System 
The sensor pixel array architecture is depicted in Fig. 2.2 with the top-level schematic 
shown in Fig. 2.3. The CMOS chip contains 9 pixel groups and 9 corresponding 
programmable signal conditioning blocks. Within each pixel group, there are 16 (4×4) tri-
modality sensor pixels and one temperature sensor. Each tri-modality pixel can be 
independently configured for voltage recording, cellular impedance measurement (voltage 
excitation/current sensing), and optical detection. Therefore, the entire sensor array 
provides 144 tri-modality sensor pixels and 9 temperature sensors. These on-chip sensing 
modalities enable real-time multi-physics cellular monitoring of extracellular voltage 
recording, cellular impedance mapping, optical opacity/luminescence detection, and 
temperature monitoring. Moreover, such pixelated multi-modality sensing scheme opens 
the door to real-time joint-modality characterization of cell samples under normal 
physiological conditions or with external chemical/physical stimulus. 
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Fig. 2.2. The multi-modality sensor array architecture (right) and the pixel group 
architecture (left). 
 
To facilitate extracellular voltage recording and impedance detection, each sensing 
electrode is AC-coupled to the cell culture medium to remove the DC voltage offset and 
drift of the electrode-electrolyte interface [10] [21]. Within each tri-modality sensor pixel, 
the sensing electrode occupies 40µm×40µm, which is shared by the extracellular voltage 
recording and impedance detection. A 40µm×40µm photodiode is also implemented in 
each pixel for cellular optical detections. Together with the in-pixel amplifiers and 
switches, the tri-modality sensor pixel occupies a footprint of 80µm×100µm. 
Circuits sharing techniques are exploited for the sensor pixel front-end circuits to 
achieve tri-modality sensing with a compact size (Fig. 2.4). In particular, one in-pixel 
operational amplifier (OA) is shared between the voltage recording mode and the current 
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modality of the tri-modality pixel, and the 144 on-chip tri-modality sensor pixels can be 
configured independently. The detailed senor pixel circuit operations are presented in the 
following sections. 
 




Fig. 2.4. The circuit schematic of the sensor pixel. 
 
Each tri-modality sensor pixel has two electrical outputs. One is the selected output 
either for the voltage recording mode or the current sensing of the impedance detection 
mode, while the other output is for the optical sensor (Fig. 2.4). At the pixel group level, 
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The selected tri-modality pixel output and the temperature sensor reading are then 
sent to the corresponding signal conditioning block, which comprises a down-conversion 
mixer, a programmable low-pass-filter (LPF), and an output variable-gain-amplifier 
(VGA) buffer. Shown in Fig. 2.3, if the selected pixel group output is from the voltage 
recording mode, it will pass through the switch EN_VR and is fed directly to the LPF and 
then the VGA buffer. The pixel group optical output or the temperature sensor reading is 
also fed directly to the LPF and then VGA by the switch EN_PD. On the other hand, if the 
pixel group output is from the current sensing in the impedance detection mode, it will first 
be sent to the double-balance mixer by the switch EN_IS for down-convertion (Fig. 2.3). 
The mixer local oscillator (LO) signal is then sequenctially set as the in-phase (I) and 
quadrature (Q) signals, so that complex impedance can be coherently detected. The down-
converted signal then passes through the LPF to filter out the unwanted mixing tones and 
the LO leakage, while the VGA serves as the output buffer.    
2.3. Sensor Pixel and Pixel Group Implementation 
Various circuit sharing techniques are exploited in the tri-modality sensor circuit to 
achieve compact pixel size and a high spatial resolution. The circuit details are presented 
below. 
2.3.1. Extracellular Voltage Recording Mode 
The pixel configuration for the voltage recording mode is shown in Fig. 2.5. In this 
mode, the control switches S2, S4, S5 and the pixel operational amplifier (OA) are turned on 
to form a low-noise voltage amplifier, while the switches S1, S3, and the optical sensor path 
are turned off. The capacitor C1 (11.2pF) blocks the DC voltage offset and drift at the 
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electrode-electrolyte interface [10] [21]. It also prevents DC currents charging the cells to 
avoid cellular damages [42]. The pixel OA is a one-stage common-source amplifier with a 
current-mirror active load. 
 
Fig. 2.5. The tri-modality pixel configured for the extracellular voltage recording mode. 
 
The low-noise pixel voltage amplifier amplifies two types of extracellular electrical 
signals, i.e., the local-field potentials (LFPs) and the action potentials (APs). The LFPs 
from the neurons represent the averaged electrical activity of the neurons surrounding the 
recording site with a typical bandwidth from sub-Hz to 300Hz. On the other hand, the 
action potentials (APs) from cardiomyocytes or neurons representing cellular electrical 
activity under excitation often with a higher frequency range from 300Hz to 10kHz [43]. 
The OA in-band closed-loop gain is set by the capacitance ratio of C1/C2 as 23.5dB. A 
MOS-bipolar pseudo-resistor [7] of 230GΩ is employed in the feedback path to bias the 
inverting input of the OA. This resistor and the feedback capacitor C2 (0.68pF) provide a 
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LFPs. Both capacitors C1 and C2 are implemented as MIM capacitors, and they are placed 
beneath the sensing electrode for area saving.  
In practice, the MOS-bipolar pseudo-resistor suffers from a leakage current. Due to 
its large resistance value (230GΩ), even a small leakage current can create a substantial 
DC voltage drop across the resistor and thus a DC offset between the inverting input and 
the output of the OA. Extensive simulations across process corners and temperature 
settings (from 15°C to 45°C) have been performed to characterize this DC voltage drop. 
The simulated DC voltage drop is less than 230mV, ensuring negligible effects on the OA 
operation. 
The non-inverting input of the in-pixel OA is biased by the reference voltage Vref 
(1.4V), shared among the 16 tri-modality pixels in each pixel group. To better control the 
DC output voltage of the in-pixel OA, a replica 230GΩ pseudo resistor and a 0.68pF 
capacitor are added between the reference voltage Vref and the non-inverting input of the 
OA. With a similar leakage current and DC voltage drop of the two pseudo resistors, the 
DC output voltage of the in-pixel OA can closely track the reference voltage Vref. 
Furthermore, a differential measurement scheme is employed in the voltage 
recording mode to suppress the common-mode noise and offset in the measurements. This 
is enabled by a pseudo reference Au electrode shared among 16 tri-modality pixels in each 
pixel group. When the switch EN_Ref_Pad is on, the reference electrode samples the 
background potential and noise of the nearby cellular environment, and this background 
potential is subtracted by the OA to achieve the differential measurement. 
 
 19
2.3.2. Optical Sensing Mode 
For the optical sensing, one reverse-biased p+/nwell/psub photodiode (40µm×40µm) 
is implemented in each tri-modality pixel (Fig. 2.4). In the optical sensing mode, only the 
switch S3 is turned on, while all the other switches and the pixel OA are turned off. The 
active pixel sensor (APS) architecture [44] is employed here, which consists of an NMOS 
reset gate, one PMOS source follower, and a PMOS cascode load. During the diode reset, 
the NMOS reset transistor is turned on and brings the diode cathode voltage to VPD. During 
the optical sensing, the NMOS reset transistor is off, and the photodiode generates the 
photon current. This current is integrated over the total parasitic capacitance of photodiode 
cathode node, and the integrated voltage is buffered by the source follower. The body node 
of the PMOS source follower is tied to its source terminal to cancel the body effect for 
improved linearity. In addition, the correlated double sampling (CDS) scheme is used to 
suppress the reset noise, DC offset, and the device flicker noise [15]. Each photodiode is 
surrounded by a metal shield to minimize the crosstalk from the adjacent pixels [13].  
2.3.3. Impedance Measurement Mode 
The cellular impedance measurement mode is configured and performed as follows. 
One pixel (V-excitation electrode) is first selected for the AC voltage excitation. This 
voltage excitation initiates an AC current through the nearby cellular structures, and 
another pixel (I-sense electrode) is enabled to detect this current. Thus, the cellular 
impedance between these two pixels can be fully characterized. Since arbitrary two pixels 
can be selected among the 144 tri-modality pixels in the sensor array, the impedance 
sensing region is fully reconfigurable. 
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Fig. 2.6. Cellular impedance measurement by voltage excitation and current sensing. 
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In practice, a 2-dimensional (2D) impedance mapping is highly useful in 
characterizing the cell location, tissue structure, and cell attachment to the surface. In this 
2D impedance mapping, after selecting each voltage excitation pixel (V-excitation 
electrode), its adjacent four pixels are then sequentially enabled for the current sensing (I-
sense electrodes), shown in Fig. 2.6. By measuring the AC currents through the four nearby 
pixels In (n=1, 2, 3, 4), the cellular impedance Zn (n=1, 2, 3, 4) between the V-excitation 
electrode and its adjacent I-excitation electrode are measured. Next, the cellular impedance 
on top of the V-excitation electrode Z5 is calculated as the average of the impedance values 
measured with the four nearby I-sensing electrodes. Considering the fact that one pixel 
group consists of 4×4 electrodes which can be configured as either V-excitation electrode 
or I-sensing electrode, this leads to a total impedance mapping resolution of 7×7 within 
one pixel group and 21×21 for the entire array chip. 
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The pixel front-end circuit configurations for the impedance measurement are further 
explained below. In the voltage excitation mode, the excitation signal is derived from an 
off-chip clock (CLK) after a divide-by-2 circuit, and a 4th order reconfigurable LPF 
suppresses its harmonic signals (Fig. 2.3). A programmable attenuator offers the desired 
attenuation and avoids saturating the current sensing circuit. The excitation voltage is then 
buffered by a 1:16 MUX to the selected excitation pixel. Within the excitation pixel (Fig. 
2.7), only the switch S1 is turned on, so that the excitation signal bypasses the pixel OA 
and fed directly to the electrode. 
In the current sensing mode, at the pixel level (Fig. 2.8), the resulting current via the 
nearby cellular environment first flows through the pixel electrode and is then converted 
to the voltage signal by the feedback capacitor C2. The frequency dependence of the 
capacitive loads (C1 and C2) is later calibrated out. The detected current signal is then 
buffered to the corresponding signal conditioning block (Fig. 2.3). To characterize the 
complex cellular impedance, a coherent quadrature down-conversion architecture is 
employed [10]. A double-balanced mixer performs the down-conversion, and its LO signal 
is derived from the same off-chip CLK signal as the voltage excitation signal to ensure the 
coherent detection. Note that the divide-by-2 circuit generates the in-phase (I) and 
quadrature (Q) LO signals, which then sequentially drive the mixer to achieve the complex 
impedance detection. The reconfigurable LPF after the mixer suppresses the unwanted 
mixing terms and the VGA buffers the impedance detection outputs (Fig. 2.3).  
The impedance measurement mode operates from 500kHz to 4MHz, sufficient to 
characterize the cellular impedance [45]. 
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Fig. 2.9. The schematic of the temperature sensor. 
 
2.3.4. Temperature Sensor 
The core of the temperature sensor is a Proportional-to-Absolute-Temperature 
(PTAT) circuit, similar to the design in [24] (Fig. 2.9). Two substrate PNP transistors (Q1 
and Q2) are biased by four identical cascode PMOS current sources with the current ratio 
of 3:1. The dynamic element matching (DEM) and chopper-stabilization schemes are 
employed to minimize the component mismatches in the PMOS current sources, the 
resistors, and the PNP transistors, and cancel the OA input DC offset. Several sets of 
complementary switches controlled by ФL and ФH perform the DEM and chopping 
operations. The DC current offset of the transistor M1 is suppressed by the cascode PMOS 
trimming current. The nine independent on-chip temperature sensors share the same 
current trimming signal. Finally, the LPF in the following signal conditioning block 
suppresses the element mismatches and DC offset and completes the DEM and chopping 
operations (Fig. 2.3). 
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Fig. 2.10. Chip microphotograph of the CMOS multi-modality sensor array chip (left), 
pixel group (middle), and pixel (right). 
 
Fig. 2.11. The schematic of the pseudo-differential double-balanced mixer and its LO 


















2.4. Signal Conditioning Block 
Nine parallel signal conditioning circuit blocks process the outputs from the 
corresponding parallel pixel groups and enhance the array throughput (Fig. 2.3). The 
programmable low-pass-filters (LPFs) and the variable-gain-amplifiers (VGAs) directly 
process the output signals from the voltage recording, optical detection, and temperature 
sensing modes, while the impedance measurement outputs are first down-converted by the 
mixers and then processed by the LPFs and VGAs. An on-chip Serial-to-Parallel-Interface 
(SPI) is integrated for digital programming. The circuit details are presented below. 
2.4.1. Down-Conversion Mixer 
A PMOS-based pseudo-differential double-balanced mixer is used to down-convert 
the measured impedance detection signal (Fig. 2.11). The mixer LO signals are derived 
from the LO buffer in the excitation generation block, and the I/Q LO signals are 
sequentially applied to the mixer for quadrature down-conversion and coherent detection 
of complex cellular impedance (Fig. 2.3). Due to the long on-chip routing between the 
mixer and the excitation generation circuit (around 1mm), shielded transmission line 
structures are used to distribute the LO signal on-chip with minimized coupling to other 
circuits. 
2.4.2. Programmable LPF and VGA 
A programmable second-order Sallen-Key LPF [46] is employed with 3-bit digital 
controls on its cut-off frequency. To optimize the trade-off between the total integrated 
noise and the bandwidth in extracellular voltage recording, the cut-off frequency of this 
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LPF is tunable from 400Hz to 600kHz. The LPF is then followed by a 5-bit VGA with a 
programmable gain from 0dB to 18dB as the output buffer for the chip.  
 
 
Fig. 2.12. (a) Measured and simulated voltage gain and (b) the input referred voltage 
noise PSD of the pixel when configured in the voltage recording mode. 
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Fig. 2.13. Measured averaged temperature sensor output voltage from the nine on-chip 
temperature sensors and the 3σ variation versus the ambient temperature. 
 
2.4.3. Voltage Excitation Generation Block 
A divide-by-2 circuit based on current-mode-logic (CML) latches are utilized to 
generate the quadrature LO signals [28]. Glitches during the divided-by-2 operation are 
removed using a Schmitt trigger. The harmonic tones in the voltage excitation signal will 
generate harmonic currents through the cells. However, these harmonic currents will be 
down-converted by the mixer through its harmonic mixing and thus distort the impedance 
measurement. Therefore, a 4th order programmable Sallen-Key LPF is employed to 
suppress these harmonic tones in the voltage excitation signal and achieves a 30dB 3rd-





































order harmonic rejection. A programmable attenuator is also employed to scale the voltage 
excitation signal and avoid saturating the current sensing circuit. 
2.5. Electrical Measurement Results 
The microphotograph of the multi-modality CMOS sensor array chip is shown in 
Fig. 2.10. The chip occupies 2.2mm×2.0mm in a standard 0.13µm CMOS process. The   
close-in views of the pixel group (560μm×500μm) and the tri-modality pixel 
(100μm×80μm) are also shown.  
To suppress the 60Hz power-line noise in the measurement, the setup is powered by 
D-type batteries and enclosed in a grounded metal box for electromagnetic isolation. The 
digital programming signals for the CMOS chip are generated by the digital I/O channels 
in a Data-AcQuisition module DAQ (Measurement Computing USB 1608G), while the 
nine parallel analog outputs from the chip are read by the parallel analog channels of the 
DAQ module and digitized by its 16-bit analog-to-digital-convertors (ADCs). 
To characterize the performance of the voltage recording mode, a Dynamic Signal 
Analyzer (Agilent 35670A) is used to measure the voltage gain, bandwidth, and the input-
referred noise power spectral density (PSD) of the sensing pixels. The voltage gain and the 
input-referred noise PSD are shown in Fig. 2.12. The measured low cut-off frequency is 
0.5Hz with a mid-band gain of 23.5dB, sufficient to detect the low-frequency cellular local 
field potentials. The difference between the simulated and measured low cut-off frequency 
is due to the inaccuracy in the modeling of the MOS-bipolar pseudo resistor. The averaged 
integrated noise from 0.5Hz to 400Hz is 11.1µVrms with a 3σ variation of 3.7µVrms. The 
averaged integrated noise from 0.5Hz to 10KHz is 12.7µVrms with a 3σ variation of 
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3.5µVrms. The measurement result matches well with the simulation. The DC power 
consumption of the pixel OA is 165µW with a supply voltage of 3.3V and a reference 
voltage of 1.4V. 
The temperature sensor is characterized using a temperature chamber (Half Cube 
Model 105). Figure 2.13 shows the measured averaged output voltage and the 3σ variations 
from the nine independent on-chip temperature sensors versus the ambient temperature. 
The temperature sensor response slope is 24mV/ºC. The maximum 3σ temperature 
variation of the nine temperature sensors is within 0.6 ºC. 
 
Fig. 2.14. Measured pixel output voltage due to the photodiode dark current and 
simulated normalized transducer gain of the in-pixel optical sensor versus photodiode 
biasing voltage VPD. 


























































































For the optical detection, the pixel photodiode dark current is characterized at 
different photodiode biasing voltages VPD (Fig. 2.14). The measurement is performed in 
a dark room, and the reset frequency is 0.05Hz with a 5% duty cycle. The dark current 
variation across the entire chip is marked using the error bar at each VPD value in Fig. 
2.14. The measured dark current increases substantially if the photodiode biasing voltage 
is above 1V. However, the transducer gain GT of the optical detection also increases with 
its reverse biasing voltage due to the decreased diode junction capacitance, as shown in (1) 
where Vout is the output voltage of the source follower (Fig. 2.4), Pinc is the incident light 
power, Rλ is the diode responsivity, T is the integration time, Cpar is the total parasitic 
capacitance of the photodiode cathode node, QE is the quantum efficiency, λ is the 
wavelength, q is the electron charge, ћ is the Planck constant, and c is the speed of the light. 
The simulated normalized transducer gain GTN is also plotted in Fig. 2.14, where the 
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Assuming a constant diode responsivity Rλ versus biasing voltage, then the 
normalized transducer gain is the capacitance ratio versus photodiode reverse-biased 
voltage. Considering the trade-off among the dark current, the transducer gain, and the 
dynamic range, the photodiode biasing voltage is chosen at 1V for general cellular optical 
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measurements, such as optical shadow imaging. However, for measurements with a low 
light intensity, e.g., bioluminescence experiments, a low VPD of 0.4V is used to minimize 
the dark current. 
2.6. Biological Measurement Results 
The proposed CMOS multi-modality sensor array supports a large variety of cell-
based assays with different sensing modalities, including extracellular LFP and AP voltage 
recording, electrochemical impedance mapping, optical shadow imaging, and 
bioluminescence detection. Moreover, as a unique functionality, it also enables concurrent 
real-time joint-modality measurement to capture complex multi-physics cellular responses 
during drug or chemical administrations. 
In this section, the packaging of the CMOS multi-modality sensor array is first 
presented. Then, the methods of culturing multiple types of cells on CMOS are introduced. 
These cells include human cardiomyocytes (CMs) derived from human embryonic stem 
cells (ESC), mouse neurons (MNs) derived from a progenitor MN green-fluorescent-
protein (GFP) reporter mouse ESC line, and a human ovarian cancer cell line (HeyA8-F8). 
These on-CMOS cultured cells are then utilized for multiple cell measurements and cell-
based assays by using the CMOS multi-modality sensor chip. These experiments 
demonstrate the functionalities of our CMOS multi-modality sensor array. 
2.6.1. CMOS Sensor Array Chip Packaging 
Gold plating is utilized to treat the pixel electrode and enhance their biocompatibility 
and robustness for biological measurements [10]-[21] (Fig. 2.10). Besides the gold plating, 
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this CMOS multi-modality sensor array chip does not require any other post processing 
step. This makes the solution compatible with low-cost mass production and useful for 
high-volume applications such as drug screening and development.  
The CMOS chip is mounted on a PCB using conductive epoxy. A 
Polydimethylsiloxane (PDMS) structure provides electrical isolation and seals the bonding 
wires while maintaining the packaging biocompatibility. The CMOS chip surface is 
directly exposed to the cell samples and the culture medium. A standard 35mm plastic cell 
culture dish with drilled-out bottom is mounted on the PCB to hold the cellular samples. A 




Fig. 2.15. The photograph of a fully packaged multi-modality sensor module. 
 
2.6.2. On-Chip Cell Culture 
Human cardiomyocytes (CMs), mouse neurons (MNs), and human ovarian cancer 
cells are successfully cultured on our CMOS multi-modality sensor chip. The cell culture 
methods are presented below. 
For culturing the mouse neurons (Fig. 2.16a), the TG25 Mouse ESCs are first 
cultured in a monolayer in the presence of the leukemia inhibitory factor (lif) until reaching 
70% confluence. Then, 1000 cell embryoid bodies (EBs) are formed by forced aggregation 
in micro-wells for 24 hours. EBs are further cultured in suspension on a rotary culture 
system for 5 more days in the presence of neural induction factors, smoothened agonist 
(SAG, 1μM) and retinoic acid (RA, 2μM). Finally, the CMOS sensor chip is sterilized 
using 70% ethanol and coated with laminin, an epithelial cell adhesion glycoprotein. EBs 




Fig. 2.16. Cell culture steps on CMOS sensor. (a) Mouse Neurons (MNs) and (b) Human 
Cardiomyocytes (CMs). 
 
Fig. 2.17. Measured input-referred extracellular voltage recording signals with and 
without human CM cells. 
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For culturing the human cardiomyocytes (Fig. 2.16b), human ESCs are first cultured 
in a monolayer until confluence. Then, cardiomyocytes are directly differentiated through 
the use of small molecules Gsk3 inhibitor and Wnt inhibitor for 14 days. Finally, the CMOS 
chip is sterilized using 70% ethanol and coated with a Matrigel matrix as a protein mixture 
layer to enhance cell culture and attachment. Cardiomyocytes are then seeded onto the 
CMOS chips as either single cells or aggregated cardio spheres [26]. 
For culturing the ovarian cancer cells (HeyA8-F8), the CMOS chip surface is 
sterilized by 70% ethanol and then washed three times with sterile Phosphate Buffered 
Saline (PBS). To increase cell adhesion to the chip surface, 0.1% gelatin is added onto the 
chip for 30 minutes before being aspirated. Gelatin is a derivative of collagen and one type 
of common extracellular matrix protein. Ovarian cancer cells are then seeded directly onto 
the CMOS chip and allowed to attach before adding 1mL of cell culture media. 
2.6.3. Extracellular Potential Recording 
Human Cardiomyocytes (CMs) are used for demonstrating the extracellular voltage 
recording of the CMOS multi-modality sensor array chip. The measured input-referred 
extracellular voltage recording signals with and without active CM cells are shown in Fig. 
2.17. Spontaneous beatings are detected and easily distinguished from the sensor noise 
floor. The measured period of the autonomous cell beating spikes is about 5~7 s, which is 
further confirmed by visual inspections through a stereo microscope. 
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2.6.4. Real-Time 2D Cellular Impedance Mapping for Cell Detachment 
Experiments 
Cell adhesion to the culture surface is essential for the growth and viability of 
mammalian cells as well as the formation of tissues. Moreover, cell attachment can be 
utilized to perform cell migration assays, which is widely used in cancer studies [48]. The 
cells and the culture medium have difference impedance, and typically the cells present 
higher cellular impedance values. Thus, the cell attachment to the CMOS chip surface can 
be detected by the 2D impedance mapping. Note that optical detections, i.e., shadow 
imaging or fluorescence microscopy, only yield the 2D distribution of the cells, and they 
cannot provide the surface attachment information.  
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A cell detachment experiment with an excitation frequency of 1MHz and an 
excitation voltage of 10-100mV is performed to demonstrate that 2D impedance mapping 
can be used to characterize the cell attachment. On-CMOS cultured human ovarian cancer 
cells (HeyA8-F8) are used in this demonstration. The cell detachment is triggered by 
applying accutase to the culture medium, and accutase is a natural enzyme mixture with 
proteolytic and collagenolytic enzyme activity. It has been widely used in the cell 
detachment, analysis of cell surface markers, virus growth assays, and tumor cell migration 
assays [47]. After the human ovarian cancer cells are seeded onto the CMOS multi-
modality sensor array chip, accutase is applied to the culture medium, and a real-time 2D 
impedance mapping is measured versus time. Typically, accutase suspends the cells within 
15 minutes. Therefore, after the accutase administration, the measured 2D cellular 
impedance is expected to first decrease and then stay constant after the cells are fully 
detached from the CMOS chip surface. The measured impedance mapping results of two 
pixel groups are shown in Fig. 2.18. A rapid impedance decrease can be seen after 8mins, 
indicating the cell detachment. The real-time measured impedance values at 8 different 
sensing pixels are further summarized in Fig. 2.19. The measured impedance values first 
decrease when accutase is applied and then become constant after full cell detachment. 
These results align well with the mechanistic effect of accutase. Therefore, the multi-
modality sensor array chip can be utilized in cell surface adhesion and cell migration 
assays, for example studying tumor cell migrations [48]. 
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Fig. 2.19. Measured impedance magnitude versus time at 8 different sensing pixels after 
accutase administration at T=0. 
 
Fig. 2.20. Real-time measured optical sensor outputs at two different sensor pixels for 
the bioluminescence experiment with human ovarian cancer cells. 
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2.6.5. Real-Time Bioluminescence Measurement 
The human ovarian cancer cells (HeyA8-F8) can constitutively express firefly 
luciferase. Thus, when luciferin is added to the culture medium, these cancer cells will 
exhibit luminescence emission. This is because luciferase catalyzes the reaction of 
luciferin, oxygen, and adenosine triphosphate (ATP) to yield unstable oxyluciferin, which 
then emits luminescence light during its relaxation back to the ground energy state. In 
general, upon the luciferin administration, the luminescence emission will reach its peak 
after about 5 minutes and can be detected for about half an hour, depending on the number 
of cells and the luciferin concentration. The bioluminescence information can be used to 
verify the viability of the HeyA8-F8 cancer cells and can be further extended to other 
bioluminescence cell-based assays. 
Since the intensity of the bioluminescence light is generally weak, the background 
noise, such as the photodiode dark current, should be suppressed and calibrated. The 
photodiode biasing voltage VPD is set as 0.4V to minimize the dark current (Fig. 2.14). 
Moreover, dark current in each sensing pixel is recorded before the measurement and then 
subtracted after the bioluminescence recoding. During the bioluminescence measurement, 
the culture medium is first removed and immediately replaced with medium supplemented 
with 200μg/mL of luciferin at T=0. The CMOS sensor chip starts data recording after a 
130-second setup time. During the optical detection, the photodiode reset pulse width is 1 
second and the repetition rate is 0.05Hz. Thus each photo current integration window is 19 
seconds, and the optical detection data is refreshed every 20 seconds. The optical sampling 
rate is sufficient to record the bioluminescence emission and can be increased if needed. 
The Correlated Double Sampling (CDS) technique is employed. The measured 
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bioluminescence emission peaks at around 300 seconds (5 minutes) after the luciferin 
administration and fully decays after 800 seconds (13.3 minutes). These data agree well 
with the luciferin mechanistic effect. This real-time bioluminescence experiment 
demonstrates that the CMOS sensor array chip is capable of measuring low-intensity 
optical signals and supports bioluminescence as one of the sensing modalities. 
2.6.6. Joint-Modality Cellular Measurement with 2D Impedance Mapping and 
Optical Shadow Imaging 
The unique advantage of the proposed multi-modality cellular sensor array is its 
capability of real-time joint-modality measurement of the same cellular samples, so that 
the living cells and tissues can be holistically characterized. 
In this experiment, we demonstrate a joint-modality cellular measurement with 2D 
impedance mapping and optical shadow imaging. Mentioned in the Section 2.6.4, the 2D 
impedance mapping monitors the cell attachment, while the optical shadow imaging can 
track the location and area information of the cells. On-chip cultured GFP labeled mouse 
neuron (MN) aggregates are used in this joint-modality experiment. 
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Fig. 2.21. Joint-modality measurement of the on-chip cultured and GPF labeled mouse 
neuron (MN) aggregates, including the reference fluorescent image (right), the optical 
shadow image (middle), and the 2D cellular impedance mapping (left). 
 
After the MNs are seeded onto the CMOS chip and reach maturation, a fluorescent 
imaging is first performed using standard fluorescent microscope as the reference imaging. 
Then, the optical shadow imaging of the MNs are captured using the underlying CMOS 
multi-modality sensor array chip. Since both images provide the 2D location and area 
information of the MN aggregates, a close matching can be found between the two images 
and shows the functionality of the optical shadow imaging (Fig. 2.21). Next, the 2D cellular 
impedance mapping is performed by the CMOS sensor array chip with an excitation 
frequency of 1MHz. Close-in views of the pixel group 9 are also shown in Fig. 2.21. 
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Although static images are shown, the multi-modality measurements by the CMOS chip 
are actually performed in a real-time fashion. 
Table 2.1. Performance Summary and Comparison with Recently Reported CMOS 
Biosensor*  
 
* This is a general comparison table for recently reported CMOS biosensors. Please note 
that these designs are tailored for different biomedical applications. 
 
Note that such a joint-modality cellular characterization provides additional cell 
information and cannot be achieved by single-modality sensing. For example, the 
measurement results of the pixel group 3 are highlighted in Fig. 2.21. The 2D shadow 
imaging indicates that MN cell aggregates are located in most of the region in the pixel 
group 3, which matches well with the reference fluorescent image. However, the 2D 
impedance mapping reports low impedance values on the upper right corner of the pixel 
group 3. This suggests that the MN cells are not fully attached in this upper right corner.  
This is potentially due to the PDMS packaging at the CMOS chip edge. These real-time 
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multi-modality measurement results thus demonstrate the unique advantage of the 
proposed multi-modality sensor. 
2.7. Conclusion 
This chapter demonstrates a fully integrated multi-modality sensor array in a 
standard 130nm CMOS process. The sensor array characterizes four different cell 
physiological parameters, i.e., extracellular voltage recording, cellular impedance 
mapping, optical shadow imaging/bioluminescence imaging, and temperature monitoring 
in a real-time joint-modality fashion. Electrical measurements and extensive biological 
experiments with different types of living cells are performed to demonstrate the 
functionalities of the proposed multi-modality sensing in holistic cell characterization, cell-
based assay and drug screening. Methods for on-CMOS culturing of different types of cells 
are also presented. A performance comparison with recently reported CMOS biosensors is 











A HIGH-DENSITY CMOS MULTIMODALITY JOINT SENSOR 
AND STIMULATOR ARRAY WITH 1024 PIXELS FOR HOLISTIC 
REAL-TIME CELLULAR CHARACTERIZATION 
This chapter presents a fully integrated CMOS multi-modality joint sensor/stimulator 
array with 1024 pixels for real-time holistic cellular characterization and drug screening. 
The proposed system consists of 4 pixel groups and 4 parallel signal-conditioning blocks. 
Every pixel group contains 16×16 pixels, and each pixel includes one 28μm×28μm gold-
plated electrode, four 12μm×12μm photodiodes, and in-pixel circuits, within a 
58μm×58μm pixel footprint. Each pixel supports real-time extracellular potential 
recording, optical detection, charge-balanced biphasic current stimulation, and cellular 
impedance measurement for the same cellular sample. The proposed system is fabricated 
in a standard 130nm CMOS process. Rat cardiomyocytes are successfully cultured on-chip. 
Measured high-resolution optical opacity images, extracellular potential recordings, 
biphasic current stimulations, and cellular impedance images demonstrate the unique 
advantages of the system for holistic cell characterization and drug screening. Furthermore, 
this paper demonstrates the use of optical detection on the on-chip cultured cardiomyocytes 




Recently, there is an increasing interest to explore hybrid biotic/abiotic systems that 
utilize built-in cellular machineries in conjunction with micro-/nano-electronics to achieve 
unprecedented sensing and actuation capabilities beyond conventional electronics-only 
devices [40] [53]-[55]. Cell-based assays are an excellent example of such “cell-
electronics” hybrid systems that present unique advantages for chemical sensing and drug 
screening [56]-[58]. First of all, compared to traditional biochemical assays, cell-based 
assays use the actual physiological responses of living cells to discover and examine new 
drugs, and therefore provide physiologically relevant information to accurately capture the 
efficacy, toxicity, and metabolism of the drug leads in cellular environments. The cell-
based screenings for drug safety and toxicity assessments are critical for new drug 
discovery. For example, cardiac toxicity is one of the main causes for drug withdrawal 
from the market [59]-[61]. Moreover, cell-based assays can potentially achieve a high 
sensitivity and specificity, in that a minute amount of drug can lead to a cascade of 
physiological responses for signal “amplification” and “filtering” and result in output 
signals that are easily detectable by electronics. Cell-based assays also support “sample-
in-answer-out” fast responses that are mostly limited by the intrinsic response time of the 
cells [34]. Therefore, cell-based assays have been widely used in numerous high-impact 
applications such as drug discovery, epidemic disease detection, and environmental 
monitoring [37] [62] [63]. In addition, cell-based assays are conducive to personalized 
medicine, as patient derived cells can be employed to test the patient-specific potency, 
efficacy, and toxicity of drugs.  
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To implement micro-/nano-electronic cellular sensors and actuators, CMOS 
processes have become a very promising technology platform due to their high 
spatiotemporal resolution, unparalleled analog and digital signal processors, low power, 
low cost, and high level of integration. A wide variety of single-modality CMOS cellular 
sensors have been successfully demonstrated to capture one category of cellular 
physiological responses, e.g., neural recording and stimulation systems [7]-[9] for 
measuring neuron activities, electrical impedance sensors [10] [12] [64] for cell-growth 
assay and detecting myocardial ischemia, pH sensors for cellular metabolism assay [65]-
[67], magnetic cell-based sensor for measuring cardiac beating rate [34] [68] [72], and 
optical sensors [13]-[15] for DNA sequencing. In parallel, CMOS actuators support various 
cellular manipulation, including electrical [73], optical [74], thermal [75], and magnetic 
[53]. 
However, when exposed to drug or biochemical stimulus, cells often exhibit complex 
behaviors that demand multi-physics and multi-parametric modeling. Therefore, a holistic 
understanding of cells with multi parametric cellular responses is of paramount importance 
[31]. The key objective is to real-time capture multi-physical cellular physiological 
responses from the same cellular sample with a high spatiotemporal resolution. In addition, 
it is highly desired to support cellular stimulations or actuations, which enable various in-
depth cellular studies. For example, electrical stimulation promotes the cardiac 
differentiation of human cardiac progenitor cells [76], and the maturation of 
cardiomyocytes derived from human embryonic stem cells [77], and it also can be used to 
study cellular behaviors under various neurological and cardiovascular diseases[78]-[82].  
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Despite many successful demonstrations of single-modality cellular sensors, such 
multi-modality cellular interface platform however remains elusive. A 144-pixel multi-
modality sensor array [16]-[18] including in-pixel extracellular potential recording, 
impedance sensing, and optical detection, is implemented with a pixel size of 
80μm×100μm, electrode size of 40μm×40μm, and photodiode size of 40μm×40μm. 
However, this multi-modality cellular sensing array suffers from poor spatial resolution, 
since each sensing pixel needs to integrate complex in-pixel circuits for multi-modal 
sensing. 
To address these challenges, in this chapter we present a 1024-pixel multi-modality 
CMOS cellular interfacing array with joint sensor and stimulator for holistic real-time 
cellular characterization and drug screening applications [19]-[20]. Each pixel can be 
independently configured to perform extracellular potential recording, cellular impedance 
sensing, and optical detection, as well as charge-balanced biphasic current stimulation. 
Each pixel contains a 28μm×28μm gold-plated electrode and four 12μm×12μm 
photodiodes, achieving 1024 multimodality pixels and 4096 optical detection sites with a 
total cellular interfacing field-of-view (FoV) of 1.85mm×1.85mm. The rat cardiomyocytes 
are successfully cultured on the CMOS chip surface coated with fibronectin. The measured 
optical shadow images of on-chip cultured rat cardiomyocytes achieve high spatial 
resolution and closely match the reference stereomicroscope images; this obviates the use 
of bulky and expensive conventional optical setups for applications where contact-based 
cell imaging is sufficient. Extracellular potential recordings are also performed at multiple 
pixels with the on-chip cultured rat cardiomyocytes and successfully capture the transient 
cardiomyocytes extracellular potentials with high signal-to-noise ratio (SNR) to measure 
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cardiac beating rates. In addition, we demonstrate that transient cardiac muscle contraction 
and relaxation events as well as their beating rates can be captured by real-time optical 
detection using our CMOS platform. This chapter is organized as follows. Chapter 3.2 
shows the system architecture and circuit details of the 1024-pixel CMOS multimodality 
cellular interfacing array. Chapter 3.3 describes in-house biocompatible packaging 
techniques for CMOS multimodality cellular interfacing array chip. The CMOS chip 
electrical characterizations are shown in chapter 3.4, and comprehensive cell-based 
measurements with on-chip cultured rat cardiomyocytes are presented in chapter 3.5. 
 
Fig. 3.1. The system-level schematic of the proposed 1024-pixel CMOS multimodality 
cellular interfacing array. 
 
3.2. Multi-Modality Joint Sensor/Stimulator Array Design 
The system-level schematic of the proposed 1024-pixel CMOS multimodality 
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corresponding signal-conditioning blocks, a clock generation block, and a serial-to-
parallel-interface (SPI) circuit. Each pixel group contains 16×16 multimodality pixels and 
shared circuits, including a voltage excitation buffer, a 7-bit charge-balanced biphasic 
current stimulator, a trans-impedance amplifier (TIA), a low-noise amplifier, an optical 
detection buffer, and a digital control unit. Each pixel has one 28μm×28μm electrode, four 
12μm×12μm photodiodes, achieving total 1024 multimodality pixels and 4096 optical 
detection sites per CMOS multimodality cellular interfacing array chip. The signal-
conditioning block includes a double-balanced mixer, a programmable low-pass filter, and 
a programmable gain amplifier to further process output cellular signals. The clock 
generation block includes a divide-by-2 circuit, programmable 6th-order low-pass filters, 
and buffers for coherent complex impedance sensing.   
 
Fig. 3.2. In-pixel circuit for extracellular potential recording, complex impedance 
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The in-pixel circuit for extracellular potential recording, complex cellular impedance 
sensing, and charge-balanced biphasic current stimulation is shown in Figure 3.2. It 
consists of a gold-plated electrode, a series DC blocking capacitor (3.8pF), a single 
transistor amplifier (W/L=20μm/2μm), a pseudo resistor (≈400GΩ), a degeneration 
resistor (10kΩ), and reconfiguration switches. Controlled by the switches, the electrode is 
either directly coupled to the shared circuits in the pixel group for complex impedance 
sensing and biphasic current stimulation (electrode 1 and electrode 2 in Figure 3.2) or ac-
coupled to the in-pixel single transistor amplifier for extracellular potential recording (I-
sens., I-ref., tail current, and gate bias in Figure 3.2). The in-pixel circuit for optical 
detection is shown in Figure 3.3. It includes a reverse-biased p+/nwell/psub photodiode, an 
NMOS transistor for periodic reset, and a PMOS source follower for readout [16]-[18]. 
Each photodiode is shielded by metal walls (metal and via) to achieve optical isolation. 
 
Fig. 3.3. In-pixel circuit for optical detection. 
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For optical detection, the photodiode cathode is first charged to the photodiode 
reverse-bias voltage Vpd with a short duration reset pulse. Then, the generated photocurrent 
discharges the cathode node until the cathode node potential become 0, which is buffered 
out by the PMOS source follower. Note that the input-referred voltage dynamic range at 
the cathode node is from Vpd to 0 and each pixel has 4 photodiodes and their corresponding 
readout circuits.  
 
Fig. 3.4. Circuit schematic when two pixels within one pixel group are configured for 
differential extracellular potential recording. 
 
Next, we will present the circuit details when the pixel group is configured for 
extracellular potential recording. Figure 3.4 shows the circuit schematic in this modality 







































256 pixels) to perform differential cellular potential detection with one pixel for the sensing 
and the other pixel as the reference. Two in-pixel transistors TR and TS, load resistors RL 
implemented in pixel group, and 4-bit digitally controlled current source implemented in 
pixel group are configured as a fully differential amplifier with high-pass response. The 
voltage gain of the front-end amplifier is programmable from 5dB-to-14dB with high-pass 
lower cut-off frequency of 0.1Hz, which is sufficient to accurately capture low-frequency 
local field potential. Compared to the active sensor pixel architecture where a low noise 
amplifier is implemented in each pixel [16]-[18], only one transistor is implemented in 
each pixel in this design, achieving a substantial pixel size reduction. In addition, compared 
to the passive sensor pixel architecture [9], the cellular voltage signals are first converted 
to current signals in pixel by the differential amplifier and then distributed in the current 
mode; this differential current-mode signaling minimizes the capacitive cross talk among 
pixels and achieves a fully differential measurement for high common-mode rejection. The 
detected biopotential signals are further amplified by pixel group low-noise amplifier with 
20.3dB voltage gain. The in-pixel degeneration resistor of 10kΩ is used to desensitize the 
mismatches between the sensing pixel transistor TS and the reference pixel transistor TR 
and between the sensing pseudo resistor and the reference pseudo resistor. The resistor 
loads RL of 100kΩ are implemented in each pixel group instead of PMOS loads to 
minimize flicker noise. The thermal noise generated by the gate bias resistor (pseudo 
resistor) is filtered out through the double-layer capacitor Cdl at the electrode-electrolyte 
interface [21] shown in Figure 3.4 and the external solution bias electrode. The simulated 
integrated input-referred noise is 10.5μVrms for the local field potential band (1-to-300Hz), 
7.7μVrms for the action potential band (300-to-6000Hz), and 12.1μVrms for cardiomyocytes 
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recording (1-to-2000Hz). The 4-bit digitally controlled tail-current source implemented in 
pixel group can adjust the tail current between 2.5μA to 37.5μA. The voltage gain of the 
programmable gain amplifier (PGA) in the signal-conditioning block is adjustable from 
1.7dB to 18.0dB, and therefore the total voltage gain is between 27dB and 52.3dB. 
 
Fig. 3.5. Circuit schematic when the pixel group is configured for coherent complex 
impedance sensing modality. 
  
Figure 3.5 shows the circuit schematic when the pixel group is configured for 
coherent complex impedance sensing. First, two adjacent pixels are selected with one for 
voltage excitation and the other for current sensing. The two selected in-pixel electrodes 
(E1 and E2) are DC-coupled and connected to voltage excitation buffer and current sensing 
TIA, respectively. The operation of coherent complex impedance sensing is as follows. 



































mode logic divide-by-2 circuit and programmable 6th-order low-pass filter. The in-phase 
signal is fed into the programmable attenuator and then drives the voltage excitation 
electrode. The resulting cellular current is flowing into the current-sensing pixel electrode, 
converted to an output voltage signal by TIA, frequency down-converted by the mixer, 
low-pass filtered, and further amplified by a PGA. The differential quadrature signals are 
sequentially applied to the mixer local oscillator (LO) port to coherently detect the complex 
cellular impedance. The simulated total trans-impedance gain for the current sensing chain 
is 4.6MΩ, including TIA gain of 129KΩ, mixer conversion gain of 13dB, and 
programmable gain amplifier gain of 18.0dB. The simulated total output voltage noise 
divided by the total trans-impedance gain with a mixer LO frequency of 100kHz and then 
integrated over a low-pass filter bandwidth of 700Hz is 54.1pArms. Since electrodes are 
DC-coupled, equal DC bias points are critical for reliable impedance sensing and 
maintaining long-term electrode integrity [21]-[23] [83]-[85]. The voltage excitation buffer 
output DC voltage, culture medium external DC bias voltage, and input DC voltage of the 
TIA are set to Vb=VDD/2 to minimize undesired faradaic charge transfer [85]. In addition, 
the sinusoidal voltage excitation amplitude is kept below 50mV. The minimum impedance 
sensing time is determined by the programmable low-pass filter RC settling time in the 
signal-conditioning block after the mixer. With a low-pass filter cut-off frequency of 
0.7kHz, the sinusoidal voltage excitation time is kept less than 4ms to minimize undesired 
electrochemical reaction at the electrode-electrolyte interface [85]. The electrode-
electrolyte interface impedance can be modeled as solution resistance Rs in series with the 
double-layer capacitance Cdl in parallel with charge transfer resistance Rct for simplicity 
[21] shown in Figure 3.4. The double-layer capacitance with the electrode size of 
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30μm×30μm for a gold electrode is between 50pF~100pF [23]. Therefore, we choose a 
relatively high frequency (100kHz-to-1MHz) to minimize the artifacts due to electrode-
electrolyte interface impedance and achieve precise cellular impedance sensing.   
 
Fig. 3.6. Circuit schematic when the pixel group is configured for the charge-balanced 
biphasic current stimulation. 
 
The charge-balanced biphasic current stimulation is critical for electrode safety and 
preventing cell damages, and its related circuits are shown in Figure 3.6. Two adjacent 
pixels are first selected with one for current stimulation and the other for 
reference/termination. Cathodic current (Scath), anodic current (Sano), and passive charge 
balancing (Scb) periods are sequentially enabled to complete the biphasic current 
stimulation and preserve charge balancing for electrode safety [21]-[23] [83]-[85]. A 7-bit 




























current (I-Ref.) are implemented to cover biphasic current-stimulation range from 100nA 
to 32μA. The current strength, cathodic/anodic pulse width, interphase delay, and inter-
pulse interval are fully programmable through SPI. 
 
 




3.3. In-House Biocompatible Packaging 
The 1024-pixel CMOS multi-modality cellular interfacing array is fabricated in a 
standard 130nm CMOS process with a chip area of 2mm×3mm (Figure 3.7). Each pixel 
occupies 58μm×58μm and contains a 28μm×28μm gold-electrode and four 12μm×12μm 
photodiodes. Thus, each CMOS array chip achieves 1024 multimodality pixels and 4096 
optical sensing sites with a wide FoV of 1.85 mm×1.85 mm. 
Since the chip directly interfaces with living cells and corrosive culture medium, 
biocompatible packaging with high-quality sealing is critical to prevent chip damage and 
permit the long-term drug effect studies using living cells [86] [87]. Standard CMOS 
processes, however, mostly use aluminum as the top metal layer and polyimide for the top 
passivation dielectric layer. To protect the aluminum electrodes in the culture medium, an 
electro-less gold plating procedure of aluminum-zinc-nickel-gold composite layers is 
applied to the bare CMOS chips and explained as follows. First, a diced CMOS chip is 
attached to the glass substrate with black wax for easy handling. The chip is then washed 
with acetone, methanol, and isopropyl alcohol, and further cleaned with oxygen plasma 
ions. Next, the diced CMOS chip on the glass substrate is immersed in aluminum etchant 
(TRANSENE) and then nitric acid to completely remove the aluminum oxide layer on the 
aluminum metal pads. Finally, the diced chip on the glass substrate is sequentially 
immersed into off-the-shelf zinc (Zincate, TRANSENE), nickel (Nickelex, TRANSENE), 
and gold (Immersion gold CF, TRANSENE) solutions following the electro-less gold 
plating procedure. As the last step, the chip is immersed in an autocatalytic gold solution 
(AuBEL, UYEMURA) to thicken the gold layer up to 1μm.  
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The electro-less gold plating process is a self-limiting process, resulting in the 
maximum plated gold thickness upto 200nm-to-300nm. This is because the gold can only 
be grown on the other seed layers such as Nickel for our case and cannot be grown on top 
of the gold. However, the deposited gold layer with the thickness of 200nm-to-300nm is 
not enough to fully cover the electrodes and/or to reliably protect the electrodes. This is 
particularly important for the long-term cell culturing and long-term cell-based 
measurements. Furthermore, compared to the passive sensing such as extracellular 
potential recording, the actuation such as biphasic current stimulation and voltage 
excitation for impedance sensing requires enhanced aluminum electrode protections.  
Therefore, after the immersion gold plating process, we immerse it into autocatalytic 
gold solution (AuBEL, UYEMURA). With autocatalytic process, the gold can be grown 
on top of the gold and thus gold layer thickness can be enhanced upto 1µm.  
 
Fig. 3.8. (a) Dark-field microscope image of the electrodes after immersion gold process. 
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Fig. 3.8. (b) Dark-field microscope image of the electrodes immersed in the autocatalytic 
gold solution for 1 minute after immersion gold process. 
 
 
Fig. 3.8. (c) Dark-field microscope image of the electrodes immersed in the autocatalytic 
gold solution for 2 minutes after immersion gold process. 
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Fig. 3.8. (d) Dark-field microscope image of the electrodes immersed in the autocatalytic 
gold solution for 3 minutes after immersion gold process. 
 
Fig. 3.8. (e) Bright-field microscope image of the electrodes immersed in the 
autocatalytic gold solution for 1 minute after immersion gold process. 
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Fig. 3.8. (f) Bright-field microscope image of the electrodes immersed in the 
autocatalytic gold solution for 3 minutes after immersion gold process. 
 
Figure 3.8. (a) shows the dark field microscope image of the electrodes right after 
the immersion gold process. The aluminum electrodes are fully covered by the gold layer 
but the gold layer thickness is below 300 nm. Note that the edge areas are particularly 
susceptible to culture medium attacks as the immersion gold cannot be grown and attached 
to the side polyimide passivation layers.  Figure 3.8. (b), Figure 3.8. (c), and Figure 3.8. (d) 
show the dark-field microscope images of the electrodes after it is immersed in the 
autocatalytic gold solution for 1 minute, 2 minutes, 3 minutes, respectively. Figures clearly 
show that the gold layer thickness is increased and the gold around the edge area of the 
electrodes is enhanced and fully covers the electrode. Figure 3.8. (e) and Figure 3.8. (f) 
show bright field microscope images of the electrodes after it is immersed in the 
autocatalytic solution for 1 minute and 3 minutes, respectively. Figure 3.8. (f) clearly shows 
the enhanced gold layer on the electrodes. However, we cannot immerse the sensor chips 
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longer than 5 minutes. This is because the gold layer attachment to the previous composite 
layer of aluminum/zinc/nickel is weakened due to the excessive volume of gold layer.  
Next, we immerse the gold-plated chip attached to glass substrate in the Dulbecco’s 
Phosphate Buffered Saline (DPBS) solution for more than 3 weeks and we do not observe 
any chemical residues or bubbles on the gold electrodes. 
 
Fig. 3.8. (g) A multimodality cellular interfacing array with gold-plated electrodes, (h) a 
standard 35mm cell-culture plate with a laser cut bottom, (i) a biocompatible and robust 
packaging with a medical epoxy and PDMS, and (j) a fully packaged sensor module.   
 63
3.4. Electrical Measurements 
In this section, we will show the electrical measurement results of the proposed 1024-
pixel CMOS multimodality cellular interfacing array. The chip is fully packaged in the 
daughter PCB and plugged into the mother PCB. The FPGA (USB-1616HS, Measurement 
Computing Corp.) is used to program the CMOS chip through on-chip SPI and readout the 
chip outputs. D-type batteries are used for power supply to remove 60Hz noise, and the 
electrical measurements are performed in a fully shielded chamber. 
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Fig. 3.9. (b) measured input-referred noise PSD for extracellular potential recording 
modality. 
 
For the extracellular potential recoding mode, the voltage gain, common-mode 
rejection ratio (CMRR), and input-referred noise power spectral density (PSD) are 
measured using the dynamic signal analyzer (Keysight 35670A) with the tail current of 
37.5μA to evaluate the extracellular potential recording functionality (Fig. 3.9 and Fig. 
3.10). The measured average total voltage gain is 52.39dB with a standard deviation σ of 
0.03dB, measured average CMRR is 67.2dB with σ of 3.94dB, and the measured low cut-
off frequency is 0.1Hz. The measured average input-referred noise is 11.7μVrms integrated 
from 1Hz to 300Hz (local field potential band) with σ=0.64μVrms and 7.08μVrms integrated 




























capture cardiomyocytes action potentials, an analog bandwidth up-to 2kHz is required. The 
measured average input-referred noise is 13μVrms integrated from 1Hz to 2000Hz with 









Fig. 3.11. Measured input-referred integrated voltage noise histogram versus different 
biasing tail current values. 
 
The integrated input-referred voltage noise is also measured on multiple pixels with 
different tail current strength of fully differential amplifier in Figure 3.4. Figure 3.11 shows 
the histogram of the measured input-referred voltage noise integrated from 300Hz to 6kHz 
(action potential band) on 20 pixels with different tail currents. The total voltage gains with 
the tail current of 2.5µA, 10µA, and 37.5µA are 45.3dB, 50.1dB, and 52.3dB, respectively. 
The histogram shows that the integrated input-referred voltage noise variations decrease 
for larger tail currents. For example, the measured average input-referred integrated noises 
from 300Hz to 6kHz with the tail current of 2.5µA, 10µA, and 37.5µA are 9.94μVrms, 




This is because the increased tail current of the differential amplifier (Figure 3.4) increases 
the override voltages of sensing pixel and reference pixel transistors TS and TR, and 
therefore, the differential amplifier is less sensitive to mismatches. For the following cell-
based measurements, we use the tail current of 37.5μA.   
 
Fig. 3.12.  Measured photodiode noise (dark current) versus photodiode reverse-bias 
voltage VPD. 
 
Next, for the cellular optical detection mode, photodiode noise (dark current) with 
respect to the photodiode reverse-bias voltage VPD is characterized and shown in Figure 
3.12. We employ the correlated-double-sampling (CDS) scheme to remove the reset noise, 
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photodiode noise characterization, we enable the optical detection modality in the dark 
room and therefore, the output voltage slope is due to the photodiode dark current 
integration. Figure 3.12 shows the measured output voltage slope decreases as the 
photodiode reverse-bias voltage Vpd decreases. However, since the input-referred voltage 
dynamic range for the photocurrent integration is from Vpd to 0 (Figure 3.3), the voltage 
dynamic range decreases as Vpd decreases. Considering the trade-off between the linearity 
and photodiode dark current, we choose Vpd of 0.8V for the following cell-based 
measurements.  
 
Fig. 3.13. Measured and simulated total output voltage noise power spectral density 





For the cellular impedance mapping mode, Figure 3.13 shows the measured and 
simulated total output voltage noise power spectral density (PSD) divided by total trans-
impedance gain ATotal for the entire current sensing chain, including the TIA, mixer, low-
pass filter, and programmable gain amplifier (Figure 3.5). The total output voltage noise is 
measured with TIA input open condition with the mixer LO frequency of 100kHz and the 
low-pass filter cut-off frequency of 700Hz. The measured total output voltage noise is then 
divided by the total trans-impedance gain ATotal. The measured input-referred current noise 
integrated over the low-pass filter bandwidth of 700Hz is 56pArms, achieving high 
sensitivity. The low noise current sensing circuit is essential to minimize the amplitude of 
the voltage excitation signal for electrode safety. Note that the trade-off exists between the 
measurement speed and the current sensing sensitivity.  
The 7-bit biphasic current stimulator is also characterized. Two adjacent pixels are 
selected with one electrode for current stimulation and the other for reference. Both 
electrodes are wire-bonded to PCB traces and connected to a load resistor. Figure 3.14 
shows the measured transient waveform for biphasic current stimulation with the load 
resistance of 33kΩ at the pulse frequency of 2Hz with the stimulation current of 10μA and 
pulse width of 0.2ms. To achieve charge balancing for electrode safety, cathodic current, 
anodic current, and passive charge balancing (discharge) periods are sequentially applied 
[89]. The pulse width, frequency, interphase delay, and current strength are fully 
programmable through the on-chip SPI.  
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Fig. 3.14. Measured transient waveform for the biphasic current stimulation at the pulse 
frequency of 2Hz with the pulse width of 0.2ms, the current of 10μA, and the load 
resistor of 33kΩ. 
 
Fig. 3.15. Measured transient waveform for the charge-balanced biphasic current 
stimulation with the capacitor load of 1nF, the pulse width of 0.2ms, and the current 














Next, two electrodes are connected to a load capacitor of 1nF. Figure 3.15 shows the 
measured cathodic current integration (negative slope) and anodic current integration 
(positive slope) on the load capacitor of 1nF with the current amplitude of 970nA, the pulse 
width of 0.2ms, and without the interphase delay. The measured cathodic current 
integration slope is 975V/s, which is close to the theoretical slope (970nA/1nF=970V/s). 
After anodic current pulse, the residual charges mainly due to the cathodic and anodic 
current strength and pulse width mismatches are properly discharged by the passive charge 
balancing period (Scb), achieving the charge balancing. The measured differential 
nonlinearity (DNL) and integral nonlinearity (INL) of the 7-bit current stimulator are 
within +0.21/-0.36LSB and +0.43/-0.52LSB, respectively, shown in Figure 3.16. 
 


























3.5. On-Chip Cultured Cell-Based Experiments 
3.5.1. On-Chip Neonatal Rat Ventricular Myocytes (NRVM) Culture 
Neonatal rat ventricular myocytes (NRVMs) were isolated from 1- to 2-day old 
neonatal rat Sprague-Dawley pups (Charles Rivers) as described previously [90] [91]. 
Three- fourths of the ventricle was excised and treated with trypsin (Worthington 
Biochemical Corporation, Freehold, NJ) overnight and then enzymatically treated with 
collagenase (Worthington Biochemical Corporation, Freehold, NJ). Freshly isolated 
NRVMs were re-suspended in M199 culture medium (Gibco) supplemented with 10% 
FBS, glucose, 2 mM GlutaMAX, penicillin, vitamin B12, HEPES buffer, and MEM non-
essential amino acids (Gibco). Two 60-minute pre-plating steps were performed to reduce 
fibroblasts and enrich cardiac myocyte content in the culture. NRVMs were transduced 
with Ad-GFP day of isolation for 2 hours in suspension at room temperature (RT). Media 
was changed 24 hours after initial transfection. Spheroids were formed using AggrewellTM 
(STEMCELL, Vancouver, Canada). The Aggrewell 400TM plate was sterile as provided 
from the vendor and was opened in a biosafety cabinet. A total of 0.5 mL of Rinsing 
Solution (STEMCELL, Vancouver, Canada) was added to each well and the plate was 
centrifuged for 2 min at 2,000g. The plate was then incubated for at least 30 minutes at RT 
or overnight at 4°C. The plate was washed with PBS prior to use and 0.5 mL of media was 
added to well and centrifuged for 3 min at 2,000g. Cell solution containing 1.2×106 
NRVMs in a 0.5 mL volume was added to each well. Aggrewell plate was centrifuged for 
5 min at 200g. Stereo microscope images are used to verify the cell distribution across the 
well. The plate was incubated overnight, and its media was replaced by removing 0.5 mL 
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from the plate edge and adding 0.5 mL fresh media. After 3 nights, the spheroids have 
formed and can be recovered from plate by gently jetting them out with a pipette. 
 
 
Fig. 3.17. (a) Stereo microscope image, (b) measured optical opacity image, and (c) 




Fig. 3.18. (a) Stereo microscope image and (b) measured optical opacity image of the 
on-chip cultured synchronous cardiomyocyte cluster. 
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The CMOS chip surface was washed with DPBS (Gibco) and coated with human 
fibronectin (Corning, Corning NY) at a concentration of 5 μg/mL for 1 hour at 37°C. 
Spheroids were added to the CMOS chip surface and allow to adhere overnight. After 24 
hours, fresh medium with 10% serum was added. Media is replaced every 2 days (Figure 
3.19) [92]. 
 
Fig. 3.19. Illustration of in-vitro measurement setup with a fully packaged multimodality 
cellular interfacing array module. 
 
3.5.2. High Resolution Optical/Impedance Imaging  
Figure 3.17 (a) shows the stereo microscope image of the on-chip cultured rat 
cardiomyocytes. The rat cardiomyocytes are well attached to the CMOS chip surface with 
successful growth. First of all, the light intensities at 4096 optical detection sites are 
measured and the measured optical opacity image is shown in Figure 3.17 (b). The 
measured optical opacity image closely matches the reference stereo microscope image 
and clearly shows the 2D distribution of the cultured rat cardiomyocytes on the CMOS 
chip surface. Furthermore, with the high spatial resolution, Figure 3.17 (b) also clearly 









indicator for cell viability tests. For example, in Figure 3.17 (b), the measured opacity 
gradient of the rat cardiomyocyte cluster inside the dotted circle using our CMOS chip 
closely matches that of the reference stereo microscope image. Therefore, the proposed 
CMOS chip demonstrates in-situ low cost optical detection, particularly useful for 
massively paralleled fully automated drug screening applications.  
Next, impedance sensing is performed on the right lower corner of the chip at 100kHz 
in Figure 3.17 (b). With the spatial resolution of 58µm, the proposed sensor can measure 
the impedance of rat cardiomyocyte spheroid/cluster. The measured rat cardiomyocyte 
spheroid/cluster impedance image is shown in Figure 3.17 (c) and closely matches the 
measured optical opacity image in Figure 3.17 (b) and the reference stereo microscope 
image in Figure 3.17 (a). The impedance image shows not only the 2D distribution of the 
cultured cell clusters on the chip surface but also the cell cluster-to-sensor surface 
attachment, which is a critical indicator for successful in vitro mammalian cell growth [31]. 
The cell adhesion is essential to the etiology and pathogenesis of diseases such as 
inflammatory diseases and oncology [57]. In addition, the cellular impedance is an 
important cell property parameter that can monitor physiological events such as myocardial 
ischemia [64] and cardiac muscle contraction [12]. 
The asynchronous cardiomyocyte spheroids in high concentration are often 
combined to form a large cardiomyocyte cluster with synchronized beating. Figure 3.18 
(a) and (b) show the reference stereo microscope image and the measured optical opacity 
image of the on-chip cultured synchronous cardiomyocyte cluster. The measured optical 
opacity image closely matches the reference stereo microscope image, and the 




Fig. 3.20. Measured extracellular potentials with on-chip cultured rat cardiomyocytes at 








Fig. 3.21. Measured extracellular potential with on-chip cultured rat cardiomyocytes 






3.5.3. Extracellular Potential Recording  
We also performed extracellular potential recordings for the on-chip cultured rat 
cardiomyocyte cluster shown in Figure 3.18. Figure 3.20 shows the measured input-
referred extracellular potentials at 4 independent recording sites labeled in Figure 3.18 (b). 
The measured extracellular potential recordings achieve high signal-to-noise ratio (SNR) 
and faithfully capture the fast action potential spikes and slow local field potentials shown 
in Figure 3.20. The measured extracellular potentials at Pixel-A and Pixel-C mostly show 
fast action potential spikes. On the other hand, the measured extracellular potentials at 
Pixel-B and Pixel-D clearly show fast action potential spikes together with slow local field 
potentials. No external filter or signal post-processing is used. The measured action 
potential spikes at 4 parallel sites are well synchronized, indicating that cardiomyocytes 
are electrochemically connected. The measured beating rate is 0.34Hz with a standard 
deviation of 0.063Hz. 
In addition, we directly add 10μL isoproterenol to the culture medium to test the cell-
based drug detection capability of the CMOS multimodality chip. The isoproterenol is a 
medication used for the treatment of bradycardia, heart block, and asthma [49]. The 
measured parallel extracellular potentials are shown in Figure 3.21 after the isoproterenol 
administration. After isoproterenol administration, the cardiomyocytes beating rate 
increases to 2.38Hz from 0.34Hz, and the cardiomyocytes beat more uniformly with a 
measured standard deviation of 0.007Hz. Also, the measured action potential spikes at 4 
parallel recording sites are well synchronized. Furthermore, the measured input-referred 
action potential spike amplitude decreases with isoproterenol. The observed 
cardiomyocytes responses well match the isoproterenol drug effects. 
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3.5.4. Optical Measurements of Cardiac Muscle Contraction and Relaxation 
The light transmittance of cardiomyocytes varies with the mechanical movements 
due to cardiac muscle contraction and relaxation [27]. We measure the real-time light 
transmittance changes of on-chip cultured rat cardiomyocytes using our CMOS multi-
modality chip, which can optically extract the cardiac beating information. For the 
measurement, we put the CMOS chip module with on-chip cultured rat cardiomyocytes 
(Figure 3.18) in the dark room and illuminate off-the-shelf LED light from the top. Since 
the incident light intensity is constant, the measured transient light intensity at the optical 
sensing sites on the CMOS chip shows the transient light transmittance of cardiomyocytes. 
Note that we perform the measurement using the same cellular sample in Figure 3.18, and 
therefore the optically measured cardiomyocytes beating rate can be directly compared 
with the measured cardiomyocytes beating rate by extracellular potential recordings 
(Figure 3.21).  
 
Fig. 3.22. Measured transient (a) chip output voltage slope for optical detection and 
transient (b) light intensity. 
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Fig. 3.23. Measured transient light intensities at 4 parallel recording sites in Figure 3.18. 
A pixel without cardiomyocytes is also recorded as the control experiment.  
 
Figure 3.22 (a) shows the real-time CMOS chip output voltage for the optical 
detection with the photodiode reset frequency of 100Hz, and Figure 3.22 (b) shows the 
measured transient light intensity extracted using correlated double sampling of the output 
voltage slope. To faithfully capture the cardiac muscle mechanical movements, we use the 
optical sampling frequency (photodiode reset frequency) of 100Hz for a temporal 
resolution of 10ms [27]. The measured transient light intensity in Figure 3.22 (b) clearly 
shows the cyclic patterns of systolic and diastolic rhythms for on-chip cultured rat 
cardiomyocytes. Figure 3.23 shows the measured real-time light intensities at 4 parallel 
recording sites labeled in Figure 3.18, recorded concurrently. The larger light intensity 
changes are observed at Pixel-B indicating stronger cardiac muscle contraction around that 
pixel compared to the other pixels. The real-time light intensities also show that the cardiac 







extracellular potential recording (Figure 3.21). The optically measured cardiomyocytes 
beating rate is 2.59Hz with the standard deviation of 0.08Hz, closely aligned with the 
extracellular potential recording results. The real-time light intensity at a pixel without 
cardiomyocytes is also measured as a control experiment and plotted together with the real-
time light intensity at Pixel-B in Figure 3.23, showing high SNR and confidence level of 
the cardiomyocytes light intensity measurements. Although we do not enable two sensing 
modalities simultaneously for each pixel, with fully integrated on-chip high-speed 
electronics, the multiple sensing modalities are multiplexed with sufficiently small time 
interval to achieve multi-modal sensing on the same on-chip cellular samples with 
biological relevance.    
3.5.5. Biphasic Current Stimulation for Cardiomyocyte Pacing 
The cell pacing experiments with the on-chip cultured rat cardiomyocytes are also 
performed. The fluorescent-microscope image, measured optical opacity image, and 
measured impedance image of the on-chip cultured rat cardiomyocytes are shown in Figure 
3.24 (a), Figure 3.24 (b), and Figure 3.24 (c), respectively. The rat cardiomyocyte spheroids 
achieve full confluency and very slow synchronized autonomous beating is observed (1 
beat/min). For cell pacing experiments, the rat cardiomyocyte spheroids are first stimulated 
at 4 independent sites (Figure 3.24) with the pulse frequency of 1Hz, the pulse width of 
200µs, and the current amplitude of 33µA. Then, we gradually increase the pulse width 
from 200µs to 4ms to measure the pacing threshold while keeping the pulse frequency and 
the current amplitude same. At the same time, the extracellular potential recordings are 
enabled at 4 independent sites (Figure 3.24) to monitor the stimulation response of the on-
chip cultured rat cardiomyocytes. Note that since the stimulation artifact could saturate the 
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potential recording amplifier, simultaneous stimulation and potential recording on the same 
location are challenging [93] [94]. Therefore, the extracellular potential recordings are 
enabled on the recording sites which are 656µm apart from the biphasic current stimulation 
sites (Figure 3.24) to allow response time delay. 
 





Fig. 3.24. (b) The measured optical opacity image of the on-chip cultured rat 
cardiomyocytes shown in Fig. 3.24. (a). 
 
Fig. 3.24. (c) The measured impedance image of the on-chip cultured rat cardiomyocytes 













Fig. 3.25. The overlay plot of the measured extracellular potential recordings at the pixel 
group1 with the on-chip biphasic current stimulation versus different biphasic current 
stimulation pulse width. 
Pulse width = 200µs
Pulse frequency = 1Hz
Current amplitude = 33µA
Pulse width = 500µs
Pulse frequency = 1Hz
Current amplitude = 33µA
Pulse width = 2000µs
Pulse frequency = 1Hz
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Fig. 3.26. (a) The reference image of the on-chip cultured HeyA8-F8 cells. (b) Measured 
optical shadow image by the CMOS chip. (c) The real-time bioluminescence 
measurement results for 3 pixels. 
 
The overlay plot of the measured extracellular potentials at the pixel group1 (Figure 
3.24) with the biphasic current stimulations is shown in Figure 3.25. The measurement 
results show that the on-chip cultured rat cardiomyocyte spheroids are successfully paced 
with the pulse width greater than 2ms and the measured capture rate is 100% with the pulse 
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width greater than 2ms. The output referred evoked action potential spike amplitude is 
538mV, which is corresponding to the input referred voltage amplitude of 1.34mV. It also 
shows that the time delay between the current stimulations and evoked action potential 
spikes, the amplitude of the spikes, and the shape of the spikes are consistent for 10 
continuous biphasic current stimulations. 
The human ovarian cancer cells (HeyA8-F8) are also cultured on the chip shown in 
Figure 3.26. First of all, the 4096 optical sensing sites are scanned and the measured optical 
opacity image is shown in Figure 3.26. (b). The measured optical opacity image closely 
matches the reference stereo microscope image (Figure 3.26. (a)), showing location, 2D 
distribution, and opacity information of the on-chip cultured human ovarian cancer cells. 
Then, we add luciferin to trigger cellular bioluminescence responses. Real-time recordings 
at 3 pixels show desired bioluminescence decaying response (Figure 3.26. (c)). 
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In this chapter, we present a 1024-pixel CMOS multimodality cellular interfacing 
array chip for holistic cell characterization and cell-based drug screening applications. 
Each pixel can be independently configured to perform extracellular potential recording, 
cellular impedance sensing, optical detection, and biphasic current stimulation. Each pixel 
size is 58μm×58μm including a 28μm×28μm gold-plated electrode and four 12μm×12μm 
photodiodes. We also present our in-house biocompatible packaging with robust solution 
resistance and demonstrate successful culturing of rat cardiomyocytes on the CMOS chip. 
The measured optical opacity image of on-chip cultured rat cardiomyocytes achieves high 
spatial resolution and closely matches the reference stereo microscope image. The 
measured extracellular potentials achieve high SNR and accurately capture the 
isoproterenol drug effects. Furthermore, real-time optical measurement of cardiomyocyte 
beating is demonstrated to record the transient cardiac muscle contraction and relaxation 
events and measure the cardiac beating rate, which aligns well with extracellular potential 
recording. The on-chip cultured rat cardiomyocytes are successfully paced with the on-
chip biphasic current stimulator, and the pacing threshold and capture rate are also 
measured. The cell-based measurement results demonstrate the utility and benefit of the 
proposed CMOS multimodality cellular interfacing array system for fully automated and 
massively paralleled drug screening and new drug development in the pharmaceutical 






A CMOS 22K-PIXEL SINGLE-CELL RESOLUTION MULTI-
MODALITY REAL-TIME CELLULAR SENSING ARRAY 
This chapter presents a single-cell-resolution multimodality cellular interfacing array 
for holistic cell characterization and high-throughput drug screening. It contains 22,528 
multimodality sensing pixels with a pixel size of 17µm×17µm. Each pixel contains a 
4µm×4µm gold-plated electrode for extracellular potential recording and a 3µm×6µm 
photodiode for optical detection. To maintain high signal to noise ratio (SNR) despite the 
large electrode-electrolyte impedance due to small electrodes, we employ a DC-coupled 
chopper amplifier for extracellular potential recording that substantially minimizes front-
end electronic noise. A proof-of-concept design is implemented in a standard 130nm 
CMOS process. It achieves a measured input-referred noise of 2.46µVrms integrated from 
1Hz to 4kHz at a chopping frequency of 20kHz, and cell-based measurements demonstrate 
real-time recorded action potentials with high SNR. Measured high-resolution optical 
shadow images provide the detailed cell and tissue morphology as well as the 2D 
distribution of on-chip cultured cells. Furthermore, this chapter presents the first CMOS 
sensing array that can successfully capture on-chip rat cardiomyocyte contraction using 





The built-in machineries in cells can be utilized in conjunction with electronic 
platforms to achieve unprecedented sensing and actuation capabilities far beyond 
conventional electronics-only devices. Cell-based assays are an excellent example of such 
“cell-electronics” hybrid systems that present unique advantages for chemical sensing and 
drug screening. First of all, cell-based assays directly use the physiological responses of 
living cells to examine new drugs, and therefore they provide physiologically relevant 
information that more accurately represents real-life biological behavior when compared 
to traditional biochemical assays. Moreover, cell-based assays can potentially achieve a 
high sensitivity/specificity as well as sample-in-answer-out fast response. Cell-based 
assays have been widely used in numerous high-impact applications such as drug 
discovery, epidemic disease detection, and environmental monitoring. In addition, cell-
based assays also support personalized medicine, as patient derived cells can be directly 
used to test the potency, efficacy, and toxicity of patient-specific medicine. 
Existing integrated cellular sensors are mostly of single-modality that only captures 
one type of cellular physiological change, e.g., extracellular potential [9], impedance [10], 
and optical absorption [13]. However, cells are highly complex systems with multi-physics 
and multi-parametric activities. For example, cells exhibit chemical activities such as 
anabolism and catabolism as well as mechanical activities including contraction, 
chemotaxis, and phototaxis. As a result, single-modality sensors cannot fully capture these 
multi-faceted responses; sensor platforms with multiple sensing modalities are necessary 
to simultaneously monitor multi-parametric cellular activities for holistic cell 
characterizations [16]-[19]. 
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However, the reported multi-modality cellular sensors suffer from poor spatial 
resolution, since each sensing pixel needs to integrate multiple sensing functionalities. 
Therefore, in this chapter, we propose and demonstrate a CMOS multimodality sensor 
array with 22,528 pixels with a pixel size of 17µm×17µm (edge-to-edge), gold-plated 
electrode size of 4µm×4µm, and photodiode size of 3µm×6µm, achieving single-cell 
resolution for typical mammalian cells (10-20µm). Each sensor pixel supports extracellular 
potential recording, and optical detection for holistic cellular characterization. Note that 
the aggressive in-pixel electrode miniaturization increases the electrode-electrolyte 
impedance [21], making low-noise extracellular potential recording challenging. We 
employ a DC-coupled chopper amplifier to substantially reduce the front-end circuit noise 
and ensure overall high SNR in extracellular potential recording. The design details, 
biocompatible packaging, electrical measurements, and cell-based measurements are 
presented in the following sections.    
4.2. A Single-Cell Resolution Multimodality CMOS Sensor Array Design 
Figure 4.1 shows the system schematic of a 22k-pixel multimodality CMOS sensor 
array. It consists of 22 pixel groups each of which includes 16×64 pixels, switch matrices, 
a DC-coupled chopper amplifier, a photodiode readout circuit, a non-overlapping clock 
generation block, and a signal conditioning block. Each pixel contains one 4µm×4µm gold-
plated electrode, one 3µm×6µm photodiode, transmission gate switches, and a buffer for 
the photodiode. Each 2×2 square of pixels can be accessed together as a sub-pixel group 
for extracellular potential recording and optical detection. For extracellular potential 
recording, two sub-pixel groups are selected, one as a sensing sub-pixel group and the other 
as a reference sub-pixel group. The signal conditioning block is composed of a high-pass 
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filter (HPF), a programmable low-pass filter (LPF), and a programmable gain amplifier 
(PGA) to process the output signals. 
 
Fig. 4.1. Schematic of a 22k-pixel multimodality CMOS sensor array. 
  
Figure 4.2 shows the detailed circuit schematic of the DC-coupled chopper amplifier 
(DCCA) for extracellular potential recording. It consists of five front-end input stages, four 
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stage contains a chopper circuit and gm cell. Note that two sub-pixel groups are selected 
and four input stages are either simultaneously enabled or sequentially enabled. For 
example, in many cases, cells are sparsely distributed and there could be only one cell or 
cell cluster within one selected sensing sub-pixel group (2×2 pixels) as shown in Fig. 
4.3(a). In this case, we can simultaneously enable the four input stages to receive correlated 
signals from one cell and combine them at the Class-AB output stage, thereby maximizing 
the SNR. Note that the non-correlated noise such as circuit noise and DC-drift/offset at the 
electrode-electrolyte interface can be averaged out while the correlated signals are 
combined in the current domain. On the other hand, when multiple cells or cell clusters are 
located within one selected sensing sub-pixel group in Fig. 4.3(b), we use a time-
multiplexing scheme among the four input stages to measure cell responses from each 
electrode individually to maximize the spatial resolution. Note that this arrangement can 
be readily extended to have more input stages with one Class-AB stage to construct a high-
density array.   
The dominant noise source for the bio-potential amplifier is the low-frequency 
flicker noise of CMOS devices [28]. Although chopping suppresses this flicker noise, it 
results in reduced amplifier input impedance (1/2fchopCDC) due to the chopping operation 
at the frequency fchop with a large input DC blocking capacitor (CDC) [96]. Note that high 
input impedance is critical for electrode safety (small DC current), low cut-off frequency, 
and high SNR (minimized signal attenuation at the electrode-electrolyte interface), 
especially for high density arrays with small electrodes. Therefore, we employ DC 
coupling at the front-end input stages, obviating the large DC blocking capacitor and 
achieving minimized input capacitance, which consists of the PMOS gate capacitance 
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shown in Fig. 4.2. Furthermore, since the chopping circuit can also largely suppress the Vth 
mismatches between PMOS differential pairs, the size of the PMOS differential pair can 
be very small. Considering the trade-off between the input capacitance and device Vth 
mismatches, we choose an input PMOS devices size of 9.8μm/240nm. The extracted input 
parasitic capacitance Cin is 2.5fF, resulting in an input impedance of 1/2fchopCin≈1GΩ at 
the chopping frequency fchop of 20kHz. In summary, DC-coupled chopping operations 
simultaneously achieve flicker noise suppression, high input impedance, and compact 
design, all of which are necessary for high-density design.  
 
Fig. 4.2. Schematic of the DC-coupled chopper amplifier. 



































































Since we employ DC coupling at the front-end input stages, special care must be 
taken for undesired DC-drifts/offsets at the electrode-electrolyte interface. The voltage gain 
of the DCCA can be programmed from 5.8dB to 33dB and the amplified DC-drift/offset is 
largely removed by the following HPF implemented in the signal conditioning block. Note 
that if we enable the four input stages simultaneously, the non-correlated DC-drift/offset 
can be averaged out, allowing us to have higher voltage gain in the DCCA.   
 
Fig. 4.3. (a) Single cell/cell cluster and (b) multiple cells/cell clusters located in the 
selected sensing pixel group.    
  
For optical detection, one reverse-biased p+/nwell/psub 3µm×6µm photodiode, 
NMOS for reset, and buffer are implemented within each pixel as shown in Fig. 4.1. The 
 96
generated photon current at the photodiode, which is proportional to light intensity, is 
integrated in its parasitic capacitance and buffered out by a PMOS source follower. 
4.3. Experimental Results 
The proposed 22k-pixel multimodality sensor array is implemented in a standard 
130nm CMOS process shown in Fig. 4.4. The entire chip occupies 4mm×4mm with a 
sensing area of 2.2mm×3.4mm, electrode size of 4µm×4µm, and photodiode size of 
3µm×6µm. We perform standard electro-less gold plating for electrode safety and for 
creating a bio-compatible interface. To facilitate testing, we package the chip on a daughter 
board connected to a mother board (Fig. 4.5).  
 
Fig. 4.4. Chip microphotograph. 
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After electro-less gold plating, we wash the chip surface using acetone, methanol, 
and isopropyl alcohol to remove organic residue in the sensing area. The chip is bonded to 
the daughter board, and the I/O pads are wire-bonded. We then apply medical epoxy to 
completely seal the bonding wires for high water resistance. Subsequently, we apply 
polydimethylsiloxane on top of the medical epoxy for biocompatibility. A standard 35mm 
cell culture plate with a laser-cut bottom is mounted onto the daughter board to contain the 
culture medium and cell samples while still housing the sensing array (Fig. 4.5). 
 
Fig. 4.5. Fully packaged module and cell-based measurement setup. 
  
After packaging, the chip is electrically characterized. Figure 4.6(a) shows the 
measured voltage gain with a 20-kHz chopping frequency. The voltage gain and high cut-
off frequency are fully programmable. Note that with a 6th-order low-pass filter 
implemented in the signal conditioning block, the chopping noise can be largely eliminated 
(-60dB/dec). Figure 4.6(b) shows the measured input-referred noise with and without 
chopping operation. The measured input referred noise integrated from 1Hz to 4kHz is 
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2.46µVrms with a chopping frequency at 20kHz. Compared to the measured integrated input 
referred noise of 17.08µVrms without chopping operation, it achieves maximum 30-dB 
noise floor reduction as shown in Fig. 4.6(b). The rat cardiomyocyte action potential 
measurement results will further confirm low-noise performance.    
 
Fig. 4.6. (a) Measured voltage gain with chopping frequency of 20kHz and (b) input-
referred noise with and without chopping operation. 
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Next, we perform cell-based measurements of on-chip cultured rat cardiomyocytes. 
First of all, 11,264 photodiodes (upper half chip) are scanned. The measured optical 
shadow image is shown in Fig. 4.7 and matches with the reference stereo microscope 
image. The measured optical shadow image depicts cell opacity, 2D cell distribution, and 
cell morphology. 
 
Fig. 4.7. Stereo microscope image and measured optical shadow image of on-chip 
cultured rat cardiomyocytes. 
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The extracellular potential recording with on-chip cultured rat-cardiomyocytes are 
performed with a 20-kHz chopping frequency, and the measured real-time action potentials 
shown in Fig. 4.8 demonstrate high SNR. The zoomed-in view of simultaneous action 
potential recording from multiple pixel groups shows that it preserves the same pattern 
over time with the action potential spike recorded at pixel group 4 always leading, showing 
action potential propagation and synchronized cardiac cell beating. 
 
Fig. 4.8. Measured action potential spike of on-chip cultured cardiomyocytes. 
  
The real-time measured action potentials of cardiomyocytes before and after 
isoproterenol administration are also shown in Fig. 4.9. After isoproterenol administration, 
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action potentials occur with faster and more uniform frequency but with decreased 
amplitude from 605.6µV to 384.3 µV, which is consistent with the expected effects of the 
isoproterenol. 
 
Fig. 4.9. Measured action potential of on-chip cultured cardiomyocytes before and after 
isoproterenol administration. 
  
Optical detection can also be used to detect when cardiomyocytes contract [27]. 
Figure 4.10 illustrates how measuring the light intensity at a single pixel can capture 
cardiomyocyte contraction, thereby detecting cell contractility. The cardiac muscle fibers’ 
contraction and relaxation can modulate the light transmittance of cardiomyocytes, and this 
modulation can be measured by the photodiode within each pixel. Figure 4.11 shows the 
measured real-time action potential and light intensity measurements. The frequency of the 
measured transient light intensity spikes aligns well with the measured action potential 
frequency, verifying that optical detection can successfully capture cardiomyocyte 
contraction. Note that action potentials occur due to the firing of ions, while the light 
After Isoproterenol AdministrationBefore Isoproterenol Administration
605.6 µV 384.3 µV
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intensity spikes come from cardiac muscle fiber contraction and relaxation. Therefore, the 
measurement results shown in Fig. 4.11 demonstrate that our proposed multimodality 
sensor can capture multi-physical cellular physiological changes on the same cellular 
sample, showing the utility and unique benefit of the proposed multimodality sensing array. 
 
Fig. 4.10. Optical measurement methods to capture cardiac muscle fiber 
contraction/relaxation events. 
 
Fig. 4.11. Measured real-time action potentials and contractility. 
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4.4. Successive Approximation ADC Measurement Results 
In this section, we will present the 10-bit successive approximation (SAR) ADC 
design and measurement results for the future work on multimodality joint sensor and 
stimulator cellular interfacing array with massively parallel recordings in chapter 5. The 
topology of the SAR ADC is presented in paper [97]. It uses a monotonic capacitor 
switching procedure to reduce average switching energy and total capacitance. Moreover, 
this topology can significantly simplify the digital circuits for successive approximation. 
The SAR ADC consists of bootstrapped switches, capacitor DACs, comparator, and SAR 
digital logic circuit. The required effective number of bits (ENOB) and sampling speed are 
9-bit and 1Msample/s. With the typical extracellular recording sampling rate of 10KHz, 
single ADC can be time-multiplexed by 100 potential recording amplifiers. In order to 
improve the linearity performance, we choose the unit capacitance value of 49fF. 
Figure 4.12 shows the measured FFT spectrum with the target sampling rate of 
1MS/s and input sinusoidal signal frequency of 200KHz. The measured signal-to-noise and 
distortion ratio (SINAD), signal-to-noise ratio (SNR), and effective number of bits (ENOB) 
are 52.4dB, 62.03 dB, and 8.4 bits, respectively. The excessive ADC output harmonic 
distortion is mainly due to the harmonic distortion of the input signal generator (Keysight 
81160A), which exhibits the harmonic distortion of -63dBc. Figure 4.13 shows the 
measured differential nonlinearity (DNL) and integral nonlinearity (INL). The measured 




Fig. 4.12. Measured FFT spectrum at 1MSample/s with the input sine wave at 200KHz. 
 
Fig. 4.13. Measured differential nonlinearity (DNL) and integral nonlinearity (INL).  
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4.5. Conclusion 
This chapter presents a 22k-pixel multimodality sensing array with a DCCA for cell 
characterization and drug screening. DCCA achieves the measured input-referred noise of 
2.46µVrms and cell-based measurements successfully capture the beating rate of 
cardiomyocytes using both optical detection and potential recording (Table 4.1.). 
Additionally, drug effects of isoproterenol are successfully characterized, and the 
cardiomyocyte culture is successfully imaged. 
 
























































Since the cell signals are encoded by temporal dynamics and spatial gradients, 
massive parallel recording channels are very important to decode the temporally coupled 
cellular signals and high spatial resolution is also critical to analyze the spatially coupled 
cellular signals. Due to the large number of combinations between diseases relevant cell 
lines and compound libraries, drug screening could be very time consuming and labor 
intensive. Therefore, high throughput is very critical for fully automated drug screening 
applications. However, with the increased spatial resolution or decreased pixel size, the 
electrode-electrolyte impedance increases substantially. The large electrode-electrolyte 
impedance results in additional noise for extracellular potential recordings and 
measurement artifacts due to the electrode-electrolyte impedance degrade the accuracy of 
the cellular impedance. 
As a future work, I will investigate in increasing the number of parallel channels for 
each modality by utilizing the time-multiplexing operation of the on-chip analog-to-digital 
converter (ADC). Also, I will further reduce the pixel size without compromising the 
number of modalities. In addition, I will investigate on the electrode materials such as 
titanium nitride and iridium oxide to minimize the electrode-electrolyte impedance and the 
electrode-electrolyte impedance artifacts. The 4-point impedance measurements will be 
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employed in the future design to precisely de-embed the electrode-electrolyte impedance 
for cellular impedance measurements. In this chapter, we will present the multimodality 
joint sensor and stimulator design architecture and potential electrode materials for low 
noise and reliable stimulations.  
5.2. Multimodality Joint Sensor and Stimulator Cellular Interfacing Array with 
Massively Parallel Recording Channels 
Figure 5.1 shows the schematic of the multimodality joint sensor and stimulator 
cellular interfacing array with massively parallel recording channels of NC. It consists of 
electrode and photodiode arrays, pixel multiplexers, potential recording amplifiers (×NC), 
optical sensing read-out buffers (×NC), one 4-point impedance measurement block, two 
successive approximation ADCs, two time multiplexers, and a digital control unit. In order 
to achieve massively parallel extracellular potential recordings with the channel number of 
NC, each channel should have individual potential recording amplifier due to the following 
reasons. Since each pixel electrode exhibits its own DC offset and/or DC drift, if the pixels 
are time-multiplexed with one shared potential recording amplifier at very fast scan rate, 
the DC offset and/or DC drift from pixels are modulated and fall into in-band frequency of 
potential recording amplifier and could saturate the following potential recording 
amplifier. Furthermore, for simultaneous recordings between extracellular potential and 




Fig. 5.1. Schematic of a multimodality joint sensor and stimulator array unit with 
massively parallel recording channels. 
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Fig. 5.2. Simulated integrated noise versus electrode dimension with different electrode 
materials.  
   
5.3. Electrode Modifications  
Figure 5.2. shows the simulated noise integrated from 0.3Hz to 20KHz versus 
electrode dimension with different electrode materials. It shows that the simulated 
integrated noises for gold, platinum bright, platinum black/glass, and titanium nitride with 
the electrode diameter of 1µm are 101µVrms, 36µVrms, 5.92µVrms, and 5.79µVrms, 
respectively. The electrode noise with gold electrode is 17.4 times larger than the electrode 
noise with titanium nitride electrode. Furthermore, the recent studies [98] show that the 
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titanium nitride and iridium oxide electrodes can reliably be used for long-term 
current/voltage stimulation with high stimulation efficacy and efficiency. Therefore, I will 



















6.1. Research Summary 
The proposed research is to develop multimodality CMOS sensor array for holistic 
cellular characterization and cell-based drug screening. Cells are the basic structural, 
functional, and biological units of all known living organisms. Understanding the 
physiological behaviors of living cells and tissues is a prerequisite to further advance 
bioscience and biotechnologies, such as synthetic biology, stem cell manufacturing, and 
regenerative medicine. Moreover, both wide-type and genetically modified cells have been 
widely used as powerful sensing and diagnostic tools in cell-based assays; these assays are 
the key enablers in numerous high-impact applications, including characterizing the 
potency, efficacy, and toxicity of new drugs in pre-clinical pharmaceutical development, 
determining the patient-specific treatments in personalized medicine, fast pathogen 
screening for epidemic disease detections, and detecting biohazards and pollutants in 
environmental monitoring. However, cells are highly complex systems often with 
concurrent multi-physics responses when subjected to external stimuli, which cannot be 
captured by conventional single-modality sensors, e.g., with electrical or optical only 
detections. Furthermore, cell signals could be encoded by spatiotemporal dynamics. Thus, 
there is an unmet need for new multi-modality sensor arrays comprised of pixels each 
capable of detecting multi-physics cellular responses together with actuations.  
In this thesis, we demonstrate a fully integrated 144-pixel multimodality sensor array 
in a standard CMOS process. The sensor array characterizes four different cell 
physiological parameters, i.e., extracellular voltage recording, cellular impedance 
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mapping, optical shadow imaging/bioluminescence imaging, and temperature monitoring 
in a real-time joint-modality fashion with the pixel size of 80µm×100µm. Electrical 
measurements and extensive biological experiments with different types of living cells are 
performed to demonstrate the functionalities of the proposed multi-modality sensing in 
holistic cell characterization, cell-based assay and drug screening. Next, this design is 
extended to a 1024-pixel multimodality joint sensor and stimulator cellular interfacing 
array. The biphasic current stimulator is added to pace the cardiomyocytes and to precisely 
capture the drug effects under the uniform pacing condition. In addition, the pixel size is 
significantly reduced to 58µm×58µm for high spatial resolution. The measured optical 
opacity image of on-chip cultured rat cardiomyocytes achieves high spatial resolution and 
closely matches the reference stereo microscope image. The measured extracellular 
potentials achieve high SNR and accurately capture the isoproterenol drug effects. 
Furthermore, real-time optical measurement of cardiomyocyte beating is demonstrated to 
record the transient cardiac muscle contraction and relaxation events and measure the 
cardiac beating rate, which aligns well with extracellular potential recording. The on-chip 
cultured rat cardiomyocytes are successfully paced with the on-chip biphasic current 
stimulator, and the pacing threshold and capture rate are also measured. The cell-based 
measurement results demonstrate the utility and benefit of the proposed CMOS 
multimodality cellular interfacing array system for fully automated and massively 
paralleled drug screening and new drug development in the pharmaceutical industry. The 
multimodality pixel resolution is further reduced to a single-cell resolution with the pixel 
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